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Marijuana Edibles and “Gummy Bears”
PAUL J. LARKIN, JR.†
For most of the last eighty years, state and federal law,1
along with international agreements to which the United
States is a signatory,2 have outlawed the cultivation,
distribution, and possession of marijuana, occasionally
punishing such conduct quite severely.3 Over the last two
† Senior Legal Research Fellow, The Heritage Foundation; M.P.P. George

Washington University, 2010; J.D., Stanford Law School, 1980; B.A., Washington
& Lee University, 1977. The views expressed in this Article are my own and
should not be construed as representing any official position of The Heritage
Foundation. I thank Lawrence A. Brett, Dr. Robert L. DuPont, David Evans,
Calvin Fay, Ed Haislmaier, Mark A.R. Kleiman, Bertha K. Madras, John
Malcolm, Kevin Sabet, Charles Stimson, and Amy Swearer for excellent
comments on an earlier version of this Article. I also thank Lawrence A. Brett
and Claudia Rychlik for outstanding research assistance. Any errors are mine.
1. See, e.g., RICHARD J. BONNIE & CHARLES H. WHITEBREAD II, THE
MARIJUANA CONVICTION: A HISTORY OF MARIJUANA PROHIBITION IN THE UNITED
STATES (Lindesmith Ctr. 1999) (1974).
2. See Single Convention on Narcotic Drugs, Mar. 30, 1961, 18 U.S.T. 1407,
amended by 1972 Protocol, Mar. 25, 1972, 26 U.S.T. 1439; Convention on
Psychotropic Substances, Feb. 21, 1971, 32 U.S.T. 543; United Nations
Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic
Substances, Dec. 20, 1988, 1582 U.N.T.S. 164; ROBIN ROOM ET AL., CANNABIS
POLICY: MOVING BEYOND STALEMATE 3, 7–8, 75–76 (2010).
3. See Hutto v. Davis, 454 U.S. 370, 371, 375 (1982) (rejecting the claim that
a forty-year sentence for possessing nine ounces of marijuana with the intent to
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decades, however, numerous states have revised their state
constitutions or criminal codes to permit marijuana use by
adults for medical or recreational purposes.4 Those
developments have led to a variety of novel issues that could
not have arisen when marijuana was deemed contraband
and was grown and sold in a sub-rosa manner.5 The ongoing
distribute it was an unconstitutional cruel and unusual punishment).
4. Since 1996, twenty-nine states and the District of Columbia revised their
laws to permit medicinal use of cannabis. State Medical Marijuana Laws, NAT’L
CONF. ST. LEGISLATURES (Feb. 15, 2018), http://www.ncsl.org/research/health/
state-medical-marijuana-laws.aspx. There is considerable regulatory variation
among those states. See, e.g., Rosalie L. Pacula et al., Words Can Be Deceiving: A
Review of Variation Among Legally Effective Medical Marijuana Laws in the
United States, 7 J. DRUG POL’Y ANALYSIS 1 (2014). The California law is so openended and has been so broadly applied that it was tantamount to a recreationaluse law. See CAL. HEALTH & SAFETY CODE § 11362.5 (West 2014) (authorizing
marijuana to be used for treatment of “cancer, anorexia, AIDS, chronic pain,
spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana
provides relief”) (emphasis added); Paul J. Larkin, Jr., Medical or Recreational
Marijuana and Drugged Driving, 52 AM. CRIM. L. REV. 453, 510–12 (2015)
[hereinafter Larkin, Drugged Driving]; cf. Deepak Cyril D’Souza & Mohini
Ranganathan, Editorial, Medical Marijuana: Is the Cart Before the Horse?, 313
JAMA 2431, 2431 (2015) (questioning why states authorize medical marijuana
for diseases such as psoriasis). Beginning in 2012, eight of those states and the
District of Columbia have gone further by legalizing the possession and
recreational use of small amounts of marijuana. For example, in the fall of 2016
California voters passed Proposition 64, which legalized the sale, possession, and
use of marijuana for recreational purposes and empowered the state to regulate
that business. Vermont will join that club on July 1, 2018, when a new state law
goes into effect permitting recreational marijuana use, albeit without large-scale
commercialization. Magdalena Cerdá et al., Association of State Recreational
Marijuana Laws with Adolescent Marijuana Use, 171 JAMA PEDIATRICS 142, 143
(2017); Michael R. Blood & Julie Watson, California Issues 1st Licenses for Legal
Pot Market, U.S. NEWS & WORLD REP. (Dec. 15, 2017, 8:34 AM),
https://www.usnews.com/news/best-states/california/articles/2017-12-15/californ
ia-issues-1st-licenses-for-legal-pot-market; Chantal Da Silva, Vermont Becomes
Ninth State to Legalize Marijuana, But Getting Pot Might Be Tricky, NEWSWEEK
(Jan. 23, 2018), http://www.newsweek.com/vermont-becomes-ninth-statelegalize-marijuana-heres-where-buy-it-787792.
5. For a sample of recently published scientific, professional, and popular
books and papers discussing those issues (in addition to the literature cited
elsewhere in this Article), see NAT’L HIGHWAY SAFETY ADMIN., U.S. DEP’T OF
TRANSP., DOT HS 812 440, MARIJUANA-IMPAIRED DRIVING: A REPORT TO CONGRESS
(2017); NAT’L ACAD. SCI., ENG’G, & MED., THE HEALTH EFFECTS OF CANNABIS AND
CANNABINOIDS: THE CURRENT STATE OF EVIDENCE AND RECOMMENDATIONS FOR
RESEARCH (2017) [hereinafter NAT’L ACAD. REP.]; OFF. OF NAT’L DRUG CONTROL
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debate over marijuana policy has generated considerable
disagreement over a host of issues,6 particularly over the
treatment of marijuana under the state liberalization
initiatives as a legitimate article of trade or medicine, even
though it remains contraband under federal law.7
One point on which everyone has agreed is that
marijuana should not be peddled to children.8 Perhaps that
POLICY, MARIJUANA MYTHS AND FACTS: THE TRUTH BEHIND 10 POPULAR
MISCONCEPTIONS (2014), http://www.nationaldec.org/goopages/pages_download
gallery/download.php?filename=19411.pdf&orig_name=418.pdf; WILLIAM J.
BENNETT & ROBERT A. WHITE, GOING TO POT: WHY THE RUSH TO LEGALIZE
MARIJUANA IS HARMING AMERICA (2015); JONATHAN P. CAULKINS ET AL.,
MARIJUANA LEGALIZATION: WHAT EVERYONE NEEDS TO KNOW (2d ed. 2016)
[hereinafter CAULKINS ET AL., MARIJUANA LEGALIZATION]; KEVIN A. SABET, REEFER
SANITY: SEVEN GREAT MYTHS ABOUT MARIJUANA (2d ed. 2018); Laura Amato et al.,
Systematic Review of Safeness and Therapeutic Efficacy of Cannabis in Patients
with Multiple Sclerosis, Neuropathic Pain, and in Oncological Patients Treated
with Chemotherapy, 41 EPIDEMIOLOGY PREV. 279 (2017); Marcus A. Bachhuber et
al., Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the
United States, 1999–2010, 174 JAMA INTERNAL MED. 1668 (2014); Alain Braillon,
Low-Risk Cannabis Use Is an Oxymoron, 107 AM. J. PUB. HEALTH e26 (2017);
June H. Kim et al., State Medical Marijuana Laws and the Prevalence of Opioids
Detected Among Fatally Injured Drivers, 106 AM. J. PUB. HEALTH 2032 (2016);
Melvin D. Livingston et al., Recreational Cannabis Legalization and OpioidRelated Deaths in Colorado, 2000–2015, 107 AM. J. PUB. HEALTH 1827 (2017);
Andrew A. Monte et al., The Implications of Marijuana Legalization in Colorado,
313 JAMA 241 (2015); David L. Nathan et al., The Physicians’ Case for Marijuana
Legalization, 107 AM. J. PUB. HEALTH 1746 (2017).
6. See, e.g., W. Hall & M. Weier, Assessing the Public Health Impacts of
Legalizing Recreational Cannabis Use in the USA, 97 CLINICAL PHARMACOLOGY
607 (2015); Angela Hawken et al., Editorial, Quasi-Legal Cannabis in Colorado
and Washington: Local and National Implications, 108 ADDICTION 837 (2013);
Todd Subritzky et al., Issues in the Implementation and Evolution of the
Commercial Recreational Cannabis Market in Colorado, 27 INT’L J. DRUG POL’Y 1
(2016); see generally Paul J. Larkin, Jr., Introduction to a Debate: “Marijuana:
Legalize, Decriminalize, or Leave the Status Quo in Place?,” 23 BERKELEY J. CRIM.
L. (forthcoming 2018) (summarizing the arguments on each side) [hereinafter
Larkin, Marijuana Debate].
7. See, e.g., Gonzales v. Raich, 545 U.S. 1, 32–33 (2005) (upholding
Congress’s Commerce Clause authority to prohibit the local cultivation and use
of marijuana in compliance with state law); United States v. Oakland Cannabis
Buyers’ Coop., 532 U.S. 483, 494–95 (2001) (holding that medical necessity is not
a defense under federal law to a charge of unlawfully distributing marijuana).
8. See THOMAS BABOR ET AL., DRUG POLICY AND THE PUBLIC GOOD 105 (2010)
(“Preventing people from becoming illicit drug users is a broadly shared goal
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is because the supporters of marijuana liberalization believe
that arguing for marijuana to be treated in the same manner
as alcohol—viz., lawfully sold but regulated—is an easier
political sell than complete legalization. Perhaps that is
because proponents of liberalization know that the political
blowback from any proposal that would allow minors free
access to marijuana would sink their efforts to legalize adult
marijuana use. Or perhaps it is because of something else
entirely. Regardless, despite the well-known adage that
advocates for any principle tend to push it to the extreme
limit of its logic,9 no one argues today that minors should be
free to use marijuana in the same manner as adults. Even
states that allow marijuana to be sold to adults for
recreational purposes deny minors that privilege.10
The problem arises of how to police that judgment with
respect to a variety of different commercial food products,
colloquially known as “edibles.” They are designed to be
eaten and often resemble food products that anyone,
including minors, would consume. Edibles allow individuals
to obtain the psychoactive benefits of using marijuana
among policymakers. When focused on young people, prevention programmes
enjoy broad popular support as well.”); e.g., COLO. CONST. art. XVIII, § 16(1)(a),
(2)(b), (3), (4) (creating a state constitutional right for only adults to use
marijuana for recreational purposes); COLO. REV. STAT. § 18-18-406 (2017); 1
COLO. CODE REGS. § 212-2.402(A) (2017) (“Licensees are prohibited from
transferring, giving, or distributing Retail Marijuana, Retail Marijuana
Concentrate, or Retail Marijuana Product to persons under 21 years of age.”);
WASH. REV. CODE § 69.50.360(3) (2017); WASH ADMIN. CODE § 314-55-095(1)
(2017). Medical and recreational uses of marijuana raise distinct concerns. See,
e.g., COLO. CONST. art. XVIII, § 16(7) (stating that recreational marijuana
amendment does not limit the rights of a medical marijuana patient); id. art.
XVIII, § 14(6) (creating special rules for medical marijuana use by minors). No
state that has permitted marijuana to be used recreationally—Alaska, California,
Colorado, Maine, Massachusetts, Nevada, Oregon, Vermont, and Washington
(along with the District of Columbia)—permits cannabis to be distributed to
minors for recreational use. See Robert J. MacCoun & Michelle M. Mello, HalfBaked—The Retail Promotion of Marijuana Edibles, 372 N. ENG. J. MED. 989,
989–90 (2015).
9. See Hein v. Freedom from Religion Found., 551 U.S. 587, 615 (2007) (lead
opinion).
10. Cerdá et al., supra note 4, at 143.
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without inhaling carcinogens.11 Edibles have two other
attractive features as well: they can contain a heavy dose of
sugar, making them enticing for people with a sweet tooth,
and they avoid the tell-tale aroma of smoked marijuana,
making them attractive for minors trying to avoid detection
by their parents.
Selling edibles poses the risk that children will find and
mistakenly consume a product that injures them and that
adolescents will find and intentionally consume the same
product. How do we prevent those results? Who should make
that decision—the local, state, or federal governments? Will
the method selected to prevent those harms infringe on the
ability of adults to purchase the same delivery mechanism?
If so, does that matter?
This Article will discuss one of those issues: namely,
whether the Food and Drug Administration (FDA) should
intervene and regulate the sale of edible forms of marijuana
to prevent the risk that children who happen upon their
parents’ “stash” will unwittingly consume it, believing that it
is a traditional form of candy, or that adolescents will
knowingly consume it, hoping for its psychoactive effects.
Part I will discuss the retail distribution of marijuana in
edible forms. Part II will identify the potential harms that
minors can suffer from the consumption of marijuana,
regardless of its form. It also explains the particular harms
that can result from distributing food containing
cannabinoids, the psychoactive ingredients in marijuana,
11. See, e.g., ROBERT L. DUPONT, THE SELFISH BRAIN: LEARNING FROM
ADDICTION 156 (1997) (“Marijuana smoke contains more tar and cancer-causing
chemicals than even cigarette smoke. One marijuana cigarette has as much
cancer-causing tar as 17 tobacco cigarettes. Marijuana smoke, like tobacco
smoke, causes bronchitis, inflammation of the airways in the lings, and chronic
respiratory illnesses.”); GEORGE F. KOOB ET AL., DRUGS, ADDICTION, AND THE BRAIN
306 (2014) (“Marijuana smoke may also have the same potential toxicity as
cigarette smoke with regard to lung function.”); Daniel G. Barrus et al., Tasty
THC: Promises and Challenges of Cannabis Edibles, RTI PRESS 2, 4 (Nov. 2016)
(stating that anecdotal consumer reports attribute interest in edibles to the
ability to use them discretely, their more relaxing state of intoxication they
provide, and the ability to avoid toxins and health risks).
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principally one known by the acronym THC.12 Part III then
discusses the options available to the local, state, and federal
governments, particularly to the U.S. Food and Drug
Administration, to prevent minors from suffering those
harms by prohibiting the distribution of marijuana edibles
that could be mistaken for candy or some other treat that a
minor could eat.
I. THE DISTRIBUTION OF MARIJUANA IN EDIBLE FORM
Legalization initiatives have led to the sale of marijuana
by private parties from brick-and-mortar buildings called
“dispensaries” when marijuana is sold for medical use.13
Those businesses sell marijuana in the traditional dried
plant form of leaves and flowers that can be smoked in
cigarettes, cigars, pipes, water pipes, and “blunts”
(marijuana wrapped in tobacco leaves), or, using today’s new
technology, vaporized and inhaled (or, to use the vernacular,
“vaped”). The psychoactive component of marijuana, THC,
also comes in the form of oil or concentrates. Another popular
medium is commercial food products, known as “edibles.”
Food is rarely used as the delivery system for drugs,
12. DUPONT, supra note 11, at 154–55; LESLIE L. IVERSEN, THE SCIENCE OF
MARIJUANA 35 (2d ed. 2008); Harold Kalant, Effects of Cannabis and
Cannabinoids in the Human Nervous System, in THE EFFECTS OF DRUG ABUSE ON
THE HUMAN NERVOUS SYSTEM 387, 387 (Bertha Madras & Michael Kuhar eds.,
2014). The technical name for THC is Δ9-tetrahydrocannabinol. The chemical
structure of THC closely resembles that of anandamide, an endogenously
produced cannabinoid, named after the Sanskrit term “ananda,” which means
“bliss.” See Bertha Madras, Drug Use and Its Consequences, in THE EFFECTS OF
DRUG ABUSE ON THE HUMAN NERVOUS SYSTEM, supra, at 11; Maximilian Peters &
Raphael Mechoulam, The Endocannabinoid System, in 2 PROFESSIONAL
PERSPECTIVES ON ADDICTION MEDICINE 31, 34–36 (Mark Sanford & Donald Avoy
eds., 2009).
13. As of September 2015, there were 385 licensed retail stores, 496 licensed
marijuana cultivators, and 141 licensed infused product manufacturers in
Colorado. Subritzky et al., supra note 6, at 1. One Arizona business has a drivethru. Marcella Baietto, Arizona’s First Medical Marijuana Drive-Thru Now Open,
AZ CENTRAL (Oct. 28, 2017), https://www.azcentral.com/story/news/nationnow/2017/10/28/arizonas-first-medical-marijuana-drive-thru-now-open/8096110
01/.
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including controlled substances.14 Edibles, however, serve in
that role. Those foods come in different forms, such as
cookies, candies, cakes, popcorn products, lozenges,
chocolates, butter, popsicles, and liquids,15 as well as the
Alice B. Toklas brownies made popular in the 1960s.16 As one
observer noted, “[e]ssentially, a cannabis culinary
professional can infuse just about anything you want to eat
with THC . . . .”17
Edibles, it seems, are quite popular among marijuana’s
consumers.18 One estimate is that between eleven and
twenty-six percent of people who have used marijuana
14. Buprenorphine (a drug that avoids the psychoactive effects of opiates and
the discomfort of withdrawal) and naloxone (an opiate antagonist) are delivered
in sublingual strips, nicotine and aspirin are delivered in gum, and a few other
drugs come in a similar form. George S. Wang et al., Association of Unintentional
Pediatric Exposures with Decriminalization of Marijuana in the United States,
63 ANNALS OF EMERGENCY MED. 684, 688 (2014) [hereinafter Wang et al.,
Multistate Study 2005–2011]. No FDA-approved medication is smoked. Herbert
D. Kleber & Robert L. DuPont, Physicians and Medical Marijuana, 169 AM. J.
PSYCHIATRY 564, 564 (2012).
15. See, e.g., 1 COLO. CODE REGS. § 212-2.103 (2017) (“‘Edible Retail Marijuana
Product’ means any Retail Marijuana Product for which the intended use is oral
consumption, including but not limited to, any type of food, drink, or pill.”); JOHN
HUDAK, MARIJUANA: A SHORT HISTORY 17–18 (2016) (noting that edibles come in
“countless forms including cookies, brownies, candies, granola, salad dressing,
and even pasta sauce.”); Katherine M. Kosa et al., Consumer Use and
Understanding of Labeling of Information on Edible Marijuana Products Sold for
Recreational Use in the States of Colorado and Washington, 43 INT’L J. DRUG
POL’Y 57, 57 (2017); MacCoun & Mello, supra note 8, at 989–90; George Sam
Wang et al., Unintentional Pediatric Exposures to Marijuana in Colorado, 2009–
2015, 170 JAMA PEDIATRICS 1, 2 (2016) [hereinafter Wang et al., Colorado Study
2009–2015]; Jennifer Maloney & David-George-Cosh, Big Brewer Makes a Play
for Marijuana Beverages, WALL ST. J. (Oct. 27, 2017), https://www.wsj.com/
articles/big-brewer-makes-a-play-for-marijuana-beverages-1509300002?mod=m
ktw&mg=prod/accounts-wsj.
16. Inspired by I LOVE YOU, ALICE B. TOKLAS (Warner Bros.-Seven Arts 1968).
Toklas was a real-life writer whose cookbook had a recipe for marijuana brownies.
17. HUDAK, supra note 15, at 20; id. at 18 (“The variety now available is a real
testament to American entrepreneurship and innovation.”).
18. A 2015 estimate was that sixteen to twenty-six percent of patients using
medical cannabis consume edible products. Ryan Vandrey, et al., Cannabinoid
Dose and Label Accuracy in Edible Medical Cannabis Products, 313 JAMA 2491,
2491 (2015).
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medicinally have consumed edibles.19 Approximately five
million units of edible products were sold in Colorado in
2014, the first year of recreational marijuana sales; one
company alone produced 40,000 THC-infused candy bars per
month.20 All told, edibles constituted forty-five percent of the
$573 million in revenue generated by legal cannabis sales in
Colorado and forty percent—more than 570,000 units—of
marijuana sales in Washington.21
The pharmacokinetics—the action of the body on a drug,
viz., metabolism, distribution, and elimination—of
inhalation and ingestion differ materially from each other.
Inhaling marijuana quickly distributes THC to the brain by
entering the circulatory system in the lungs, providing the
user with the hoped-for psychoactive effect without delay. By
contrast, ingesting marijuana through an edible takes far
longer to achieve that effect because the food must be
digested and pass through the liver, which metabolizes much
of the THC, before it becomes available to the brain.22 As a
result, someone unfamiliar with the pharmacokinetics of
marijuana, such as a minor or first-time user, or someone
who travels to a state with liberal marijuana laws for the
purpose of trying out cannabis, a so-called “marijuana
tourist,” might overconsume the amount of THC-laced food
necessary to receive the effect and, instead, wind up with a
very unpleasant experience and a trip to the emergency

19. Barrus et al., supra note 11, at 2.
20. Id.; Kosa et al., supra note 15, at 57; Subritzky et al., supra note 6, at 3;
see also Jane A. Allen et al., New Product Trial, Use of Edibles, and Unexpected
Highs Among Marijuana and Hashish Users in Colorado, 176 DRUG & ALCOHOL
DEPENDENCE 44, 46 (2017) (noting that in Colorado in 2014, more than seventy
percent of a sample of past-year marijuana and hashish users tried a new product
and half of them consumed an edible).
21. Barrus et al., supra note 11, at 2; Kosa et al., supra note 15, at 57; Wang
et al., Colorado Study 2009–2015, supra note 15, at 2.
22. IVERSEN, supra note 12, at 41–47, 129; Barrus et al., supra note 11, at 3–
5; NAT’L INST. ON DRUG ABUSE, MARIJUANA 2–3 (Aug. 2017) [hereinafter NAT’L
INST., MARIJUANA].
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room.23
Inhaled and edible versions of marijuana have another
important difference, too. Businesses have developed edibles
that resemble the traditional candies attractive to children.
Some edibles resemble “Gummy Bears,” while others have
been labeled as “Pot Tarts,” “Buddahfinger,” “Munchy Way,”
or Keef Kat.”24 That clever—perhaps too clever—marketing
strategy raises a serious medical and public policy issue
because THC produces harmful effects in minors that do not
occur in adults due to the materially different stages of
neurological development for the two groups. This presents
state and federal governments with a legal problem that did

23. MacCoun & Mello, supra note 8, at 989–90. That may be what happened
to Maureen Dowd when she ate a THC-laced candy bar in Colorado. Maureen
Dowd, Don’t Harsh Our Mellow, Dude, N.Y. TIMES (June 3, 2014),
https://www.nytimes.com/2014/06/04/opinion/dowd-dont-harsh-our-mellow-dude
.html; see also HUDAK, supra note 15, at 17 (discussing what has been called the
“Maureen Dowd Effect”); Allen et al., supra note 20, at 46; Barrus et al., supra
note 11, at 5 (noting that 65 percent of edible users have an adverse experience
and that “[t]he lack of consistency and the delayed intoxication may cause both
new and experienced users of cannabis to consume higher than intended amounts
of the drug. Edible products are responsible for the majority of health care visits
due to cannabis intoxication, which is likely due to the failure of users to
appreciate the delayed effects.”).
24. See Barrus et al., supra note 11, at 6; MacCoun & Mello, supra note 8, at
990; Jack Healy, New Scrutiny on Sweets with Ascent of Marijuana, N.Y. TIMES,
Oct. 30, 2014, at A13. The same fundamental mistake—marketing marijuana
products to minors—sank reform efforts in the 1970s. See EMILY DUFTON, GRASS
ROOTS: THE RISE AND FALL AND RISE OF MARIJUANA IN AMERICA 75 (2017) (“the
movement’s peak [in the 1970s] also brought with it the movement’s downfall.
Much of the new paraphernalia for sale deliberately riffed on children’s toys, as
smokers were offered everything from pot-themed Frisbees and board games to
Christmas stockings. Even more troubling, children were quickly becoming the
targets of paraphernalia marketing themselves. By 1978, newspapers were
reporting that kids had easy access to head shops and were able to purchase
pipes, papers, and bongs with no questions asked. The paraphernalia market that
sprang up in the wake of decriminalization developed too quickly for government
oversight and, with its interest in profits and giving the growing smoking
population what it desired, it also chose not to regulate itself. In doing so, it set
itself up for its own demise when a new generation of marijuana activists—
parents angry at the rising rate of adolescent pot use—emerged in the wake of
the paraphernalia boom. Once they made their power felt, it would be decades
before decriminalization was spoken of positively in Washington again.”).
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not occur before the state legalization efforts began: what to
do about the open-and-obvious public commercial
distribution of food containing an illegal substance that
poses unique harms for minors.
II. THE PROBLEM OF MARIJUANA USE BY MINORS
Advocates for the liberalization of the marijuana laws
argue that, because marijuana is no more harmful than
alcohol, the government should treat the two drugs alike,
allowing cannabis to be regulated and sold. Treating
marijuana like alcohol during Prohibition not only deprives
people of its benefits in the medicinal treatment of conditions
like chemotherapy-induced nausea, epilepsy-induced
seizures, and multiple sclerosis spasticity, but also leads to
considerable social harms.25 A better approach, supporters
25. The most commonly cited therapeutic uses of cannabinoids are for the
treatment of chemotherapy-induced nausea and emesis, AIDS-induced anorexia
and cachexia (HIV/AIDS wasting), and the neuropathic pain and spasticity
caused by multiple sclerosis. See, e.g., BRITISH MED’L ASS’N, THERAPEUTIC USES OF
CANNABIS 21–49 (1997); NAT’L ACAD. REP., supra note 5, at 53–54 (listing
conditions for which marijuana is a treatment for which there are varying
degrees of scientific support); HUDAK, supra note 15, at 15, 22 (noting that
cannabidiol, an ingredient of cannabis ingredient, has anticonvulsive and antiinflammatory properties); JERROLD S. MEYER & LINDA F. QUENZER,
PSYCHOPHARMACOLOGY: DRUGS, THE BRAIN, AND BEHAVIOR 410–11 (2d ed. 2018);
Alan J. Budney et al., Cannabis, in LOWINSON AND RUIZ’S SUBSTANCE ABUSE: A
COMPREHENSIVE TEXTBOOK 233 (Pedro Ruiz & Eric Strain eds., 5th ed. 2011); see
also Marcus A. Bachhuber et al., Medical Cannabis Laws and Opioid Analgesic
Overdose Mortality in the United States, 1999–2010, 174 JAMA INTERNAL MED.
1668 (2014) (reporting that there were fewer opioid overdoses in states with
medical marijuana laws); Wayne Hall & Louisa Degenhardt, Adverse Health
Effects of Non-Medical Cannabis Use, 374 LANCET 1383, 1389 (2009) (“The public
health burden of cannabis use is probably modest compared with that of alcohol,
tobacco, and other illicit drugs.”); Gemayel Lee et al., Medical Cannabis for
Neuropathic Pain, 22 CURRENT PAIN & HEADACHE REP. 8 (2018) (“Nearly 20 years
of clinical data supports the short-term use of cannabis for the treatment of
neuropathic pain.”); Philip McGuire et al., Cannabidiol (CBD) as an Adjunctive
Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial, 175 AM.
J. PSYCHIATRY 225 (2018); Madeline H. Meier et al., Associations between
Cannabis Use and Physical Health Problems in Early Midlife: A Longitudinal
Comparison of Persistent Cannabis versus Tobacco Users, 73 JAMA PSYCHIATRY
731 (2016); Theresa H.M. Moore et al., Cannabis Use and Risk of Psychotic or
Affective Mental Health Outcomes: A Systematic Review, 370 LANCET 319 (2007);
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argue, is to legalize and regulate the growth and distribution
of marijuana and its products.26 That regulation would
exclude minors from recreational use.27
Opponents fundamentally disagree with liberalization’s
supporters over the relative safety of marijuana. They argue
that, at bottom, marijuana is a harmful substance. As Dr.
Nora Volkow, Director of the National Institute on Drug
Penny F. Whiting et al., Cannabinoids for Medical Use: A Systematic Review and
Meta-Analysis, 313 J. AM. MED’L ASS’N 2456, 2467 (2015); see generally CAULKINS
ET AL., MARIJUANA LEGALIZATION, supra note 5, at 67–68, 88–89, 131–57
(collecting arguments and authorities). In that regard, supporters contend that
smoking marijuana provides benefits not offered by other THC delivery vehicles
(e.g., pills, inhalants, and suppositories) approved by the U.S. Food and Drug
Administration (e.g., Dronabinol) or other nations (e.g., Nabiximol), because
inhalation works more effectively and more quickly, reaching the brain within
seconds. See, e.g., NAT’L ACAD. REP., supra note 5, at 54; IVERSEN, supra note 12,
at 41–47; Sunil K. Aggarwal et al., Medicinal Use of Cannabis in the United
States: Historical Perspectives, Current Trends, and Future Directions, 5 J.
OPIOID MGMT. 153, 163–64 (2009); see generally Larkin, Marijuana Debate, supra
note 6 (manuscript at 2–4, nn.9–21) (summarizing arguments and collecting
authorities). The World Health Organization (WHO) Expert Committee on Drug
Dependence (ECDD) recently recommended examining the proper classification
“[p]reparations containing almost exclusively CBD” because they are not likely
to be addictive and can be used for medical purposes, such as calming spasms
during epileptic fits. See WORLD HEALTH ORGAN., CANNABIDIOL (COMPOUND OF
CANNABIS): ONLINE Q&A (Dec. 2017), http://www.who.int/features/qa/
cannabidiol/en/; ESSENTIAL MEDICINES AND HEALTH PRODUCTS, WHO
RECOMMENDS THE MOST STRINGENT LEVEL OF INTERNATIONAL CONTROL FOR
SYNTHETIC OPIOID CARFENTANIL (DEC. 2017), http://www.who.int/medicines/
news/2017/WHO-recommends-most-stringent-level-int-control/en/
(“Recent
evidence from animal and human studies shows that [cannabidiol’s] use could
have some therapeutic value for seizures due to epilepsy and related conditions.
Current evidence also shows that cannabidiol is not likely to be abused or create
dependence as for other cannabinoids (such as [THC], for instance). The ECDD
therefore concluded that current information does not justify scheduling of
cannabidiol and postponed a fuller review of cannabidiol preparations to May
2018, when the committee will undertake a comprehensive review of cannabis
and cannabis related substances.”); Letter from Dr. Tedros Ahhanom
Ghebreyesus, Director-General, WHO, to Antonio Guterres, Secretary-General of
the United Nations (Nov. 27, 2017) (noting that the WHO ECDD recommended
a later “critical review” of “[p]reparations containing almost exclusively
cannabidiol (CBD)” (emphasis omitted)); id. Annex 1, at 7.
26. See, e.g., CAULKINS ET AL., MARIJUANA LEGALIZATION, supra note 5, at 131–
57.
27. See id. at 131.

324

BUFFALO LAW REVIEW

[Vol. 66

Abuse, once wrote, “[m]arijuana is not a benign drug. It is
illegal and has significant adverse health effects and
consequences associated with its use.”28 Opponents maintain
that marijuana use can be harmful to adults,29 but can cause
28. Nora D. Volkow, Marijuana and Medicine: The Need for a Science-Based
Approach, in Sanford & Avoy, supra note 12, at 23, 28; see also NAT’L INST.,
MARIJUANA, supra note 22, at 14 (endnote omitted) (“Marijuana use can lead to
the development of problem use, known as a marijuana use disorder, which takes
the form of addiction in severe cases. Recent data suggest that 30 percent of those
who use marijuana may have some degree of marijuana use disorder.”); NAT’L
INST., MARIJUANA, supra, at 3 (“[C]ontrary to popular belief, marijuana can be
addictive, and its use during adolescence may make other forms of problem use
or addiction more likely.”); WAYNE HALL & ROSALIE LICCARDO PACULA, CANNABIS
USE AND DEPENDENCE: PUBLIC HEALTH AND PUBLIC POLICY (2003) (“A cannabis
dependence syndrome occurs in heavy chronic users of cannabis. Regular
cannabis users develop tolerance to THC, some experience withdrawal symptoms
on cessation of use, and some report problems controlling their cannabis use. The
risk of dependence is about one in ten among those who ever use the drug,
between one in five and one in three among those who use cannabis more than a
few times, and around one in two among daily users.”); David A. Gorelick et al.,
Diagnostic Criteria for Cannabis Withdrawal Syndrome, 123 DRUG & ALCOHOL
DEPENDENCE 141 (2012); Deborah S. Hasin et al., Prevalence of Marijuana Use
Disorders in the United States Between 2001–2002 and 2012–2013, 72 JAMA
PSYCHIATRY 1235 (2015); Sheryl Ryan & Seth D. Ammerman, Counseling Parents
and Teens About Marijuana Use in the Era of Legalization of Marijuana, 139
PEDIATRICS E2 (2017) [hereinafter Ryan & Ammerman, Counseling Parents and
Teens]. As if to make a bad situation worse, according to a 2015 publication by
the Centers for Disease Control and Prevention, individuals who are addicted to
marijuana are three times as likely to become addicted to heroin. See Today’s
Heroin Epidemic Infographics, CTRS. DISEASE CONTROL & PREVENTION,
https://www.cdc.gov/vitalsigns/heroin/infographic.html (last updated July 7,
2015).
29. See, e.g., U.S. DEP’T HEALTH & HUM. SERVS., FACING ADDICTION IN
AMERICA: THE SURGEON GENERAL’S REPORT ON ALCOHOL, DRUGS, AND HEALTH 65
(Nov. 2016); WORLD HEALTH ORG., THE HEALTH AND SOCIAL EFFECTS OF
NONMEDICAL CANNABIS USE 15 (2016) [hereinafter WHO REPORT] (“The daily use
of cannabis over years and decades appears to produce persistent impairments
in memory and cognition, especially when cannabis use begins in
adolescence . . . .”); AM. PSYCHIATRIC ASS’N, DIAGNOSTIC AND STATISTICAL MANUAL
OF MENTAL DISORDERS 509–16 (5th ed. 2013) [hereinafter DSM-5] (discussing
“Cannabis Use Disorder”); HALL & PACULA, supra note 28; MEYER & QUENZER,
supra note 25, at 416 (“Heavy cannabis use for a long period of time may lead to
impaired executive functioning for at least 2 to 3 weeks following cessation of
use. . . . However, some of the data suggest that heavy, long-time users may
continue to show impairment in decision making, planning, and concept
formation.”); id. at 420 (ten percent of marijuana users become dependent, while
fifty percent of daily users do so); id. at 422–25 (discussing potential adverse
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psychological, neuropsychiatric, and physiological effects from long-term use); id.
at 424–25 (discussing potential psychosis-causing effect of early-onset, long-term
use); ROOM ET AL., supra note 2, at 25 (“The risk of dependence is about 9% among
persons who have ever used cannabis . . . and about one in six for young people
who initiate in adolescence,” although the risk of dependence is greater for
nicotine, alcohol, stimulants, cocaine, and heroin); id. at 27 (“There are good
reasons for believing that cannabis can cause cancers of the lung and
aerodigestive tract . . . .”); id. at 43–44 (summarizing potential harms); Budney
et al., in Ruiz & Strain, supra note 25, at 214 (“Clearly cannabis misuse and
addiction are real and relatively common phenomenon that pose a significant
public health issue . . . .”); id. at 227–28 (“Whether or not cannabis use can induce
acute psychosis or contribute to the development of more chronic psychotic
disorders (e.g., schizophrenia) also remains controversial, although data
supporting such a causal relationship are emerging. . . . Estimates of attributable
risk suggest that cannabis may play a role in approximately 1 of 10 cases.”)
(endnote omitted); Madras, supra note 12, at 16–17, 19–25; Kalant, supra note
12, at 387–412; Bertha Madras, Introduction, in CELL BIOLOGY OF ADDICTION 1, 8
(Bertha Madras et al. eds., 2006); Peter Allebeck, Psychopathological
Manifestations of Cannabis Use, in DRUG ABUSE IN THE DECADE OF THE BRAIN
159–65 (Gabriel G. Nahas & Thomas F. Burks eds., 1997); Rabi Abouk & Scott
Adams, Examining the Relationship between Medical Cannabis Laws and
Cardiovascular Deaths in the US, 53 INT’L J. DRUG POL’Y 1, 5 (2018) (“Our study
finds evidence suggesting that MCL [viz., medical cannabis legalization] was
followed by increased cardiac mortality in states passing such laws compared
with those that did not. This effect was concentrated among older individuals,
particularly males, and states where there are less restrictions on dispensaries
and cardholders.”); Louise Arseneault et al., Causal Association Between
Cannabis and Psychosis: Examination of the Evidence, 184 BRIT. J. PSYCHIATRY
110, 113 (2004); Amber L. Bahorik et al., Adverse Impact of Marijuana Use on
Clinical Outcomes Among Psychiatry Patients with Depression and Alcohol Use
Disorder, 259 PSYCHIATRY RES. 316, 320–21 (2017); Wilson M. Compton et al.,
Marijuana Use and Use Disorder in Adults in the USA, 2002–2014: Analysis of
Annual Cross-Sectional Surveys, 3 LANCET PSYCHIATRY 954, 961 (2016); Marta Di
Forti et al., Proportion of Patients in South London with First-Episode Psychosis
Attributable to Use of High Potency Cannabis: A Case-Control Study, 2 LANCET
PSYCHIATRY 233, 236 (2015) (“People who used cannabis or skunk every day were
both roughly three times more likely to have a diagnosis of a psychotic disorder
than were those who never used cannabis . . . .”); Herman Friedman,
Neuroimmunology and Marijuana, in DRUG ABUSE IN THE DECADE OF THE BRAIN,
supra note 29, at 145–51; Wayne Hall, What Has Research over the Past Two
Decades Revealed about the Adverse Health Effects of Recreational Cannabis
Use?, 110 ADDICTION 19, 29–30 (2015); Hall & Degenhardt, supra note 25;
Hannah J. Jones et al., Association of Combined Patterns of Tobacco and
Cannabis Use in Adolescence with Psychotic Experiences, 75 JAMA PSYCHIATRY
240 (2018); Peter Manza et al., Subcortical Local Functional Hyperconnectivity
in Cannabis Dependence, 3 BIOLOGICAL PSYCHIATRY: CNNI 285 (2017); Mark
Olfson et al., Cannabis Use and Risk of Prescription Opioid Use Disorder in the
United States, 175 AM. J. PSYCHIATRY 47, 49–50 (2018); Nadia Solowij et al.,
Differential Impairments of Selective Attention due to Frequency and Duration of
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even greater injury to minors, especially if it leads to heavy
or long-term use.30 Several respected government and
Cannabis Use, 37 BIOLOGICAL PSYCHIATRY 731, 737 (1995); Marie Stefanie Kejser
Starzer et al., Rates and Predictors of Conversion to Schizophrenia or Bipolar
Disorder Following Substance-Induced Psychosis, 175 AM. J. PSYCHIATRY 345
(2017) (“We found that 32.2% of patients with a substance-induced psychosis
later converted to either bipolar disorder or schizophrenia. The highest
conversion rate (47.4%) was found for cannabis-induced psychosis. Young age
was associated with a higher risk of conversion to schizophrenia; the risk was
highest for those in the range of 16–25 years. Self-harm after a substance-induced
psychosis was significantly linked to a higher risk of converting to both
schizophrenia and bipolar disorder.”); Nora D. Volkow et al., Adverse Health
Effects of Marijuana Use, 370 NEW ENG. J. MED. 2219, 2220 (2014). An additional
type of harm can result from attempts to extract THC from marijuana in home
laboratories. See Monte et al., supra note 5, at 241–42 (“The University of
Colorado burn center has experienced a substantial increase in the number of
marijuana-related burns. In the past 2 years, the burn center has had 31
admissions for marijuana-related burns; some cases involve more than 70% of
body surface area and 21 required skin grafting. The majority of these were flash
burns that occurred during THC extraction from marijuana plants using butane
as a solvent.”).
30. See WHO REPORT, supra note 29, at 16 (“Accumulating evidence reveals
that regular, heavy cannabis use during adolescence is associated with more
severe and persistent negative outcomes than use during adulthood.”); KOOB ET
AL., supra note 11, at 269, 279–87 (2014); ROOM ET AL., supra note 2, at 31–39
(describing studies investigating the risk that adolescent marijuana use could
adversely affect learning, result in a greater drop-out rate, be a prelude to other
drug use, or lead to schizophrenia or depression); Madras, supra note 12, at 14–
15; Hall, supra note 29, at 24–26; Volkow, supra note 29, at 2220 (noting that
negative effects in brain development, educational outcome, cognitive
impairment, and life satisfaction are “strongly associated with initial marijuana
use early in adolescence”); see also Manzar Ashtari et al., Diffusion Abnormalities
in Adolescents and Young Adults with a History of Heavy Cannabis Use, 43 J.
PSYCHIATRIC RES. 189, 201–02 (2009); Carlos Blanco et al., Cannabis Use and
Incidence of Psychiatric Disorders: Prospective Evidence from a US National
Longitudinal Study, 73 JAMA PSYCHIATRY 388 (2016); Matthijs G. Bossong &
Raymond J.M. Niesink, Adolescent Brain Maturation, the Endogenous
Cannabinoid System and the Neurobiology of Cannabis-Induced Schizophrenia,
92 PROGRESS NEUROBIOLOGY 370 (2010); J. S. Brook et al., Early Adolescent
Marijuana Use: Risks for the Transition to Young Adulthood, 32 PSYCHOL. MED.
79 (2002); R. Andrew Chambers et al., Developmental Neurocircuitry on
Motivation in Adolescence: A Critical Period of Addiction Vulnerability, 160 AM.
J. PSYCHIATRY 1041 (2003); Michael D. De Bellis et al., Neural Mechanisms of
Risky Decision-Making and Reward Response in Adolescent Onset Cannabis Use
Disorder, 133 DRUG & ALCOHOL DEPENDENCE 134 (2013); Donald M. Dougherty
et al., Impulsivity, Attention, Memory, and Decision-Making Among Adolescent
Marijuana Users, 226 PSYCHOPHARMACOLOGY 307 (2013); David M. Fergusson &
Joseph M. Bolden, Cannabis Use and Later Life Outcomes, 103 ADDICTION 969,
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private organizations—the American Medical Association,
the American Psychiatric Association, the American
Academy of Pediatrics, the American Cancer Society, the

969 (2008); D. M. Fergusson et al., Cannabis Dependence and Psychotic
Symptoms in Young People, 33 PSYCHOL. MED. 15, 20 (2003); Charles B. Fleming
et al., Examination of the Divergence in Trends for Adolescent Marijuana Use and
Marijuana-Specific Risk Factors in Washington State, 59 J. ADOLESCENT HEALTH
269, 269–70 (2016); Jodi M. Gilman et al., Cannabis Use Is Quantitatively
Associated with Nucleus Accumbens and Amygdala Abnormalities in Young
Adult Recreational Users, 34 J. NEUROSCIENCE 5529, 5537 (2014); Hall, supra
note 11, at 24–26; Kim Kiser, Rocky Mountain Reality, MINN. MED., Apr. 2014, at
12, 12 (interview with Jan Kief, M.D.) (“Seventy-four percent of teens in the
Denver area who are in treatment said they used someone else’s medical
marijuana on average 50 times.”); Dan I. Lubman et al., Cannabis and Adolescent
Brain Development, 148 PHARMACOLOGY & THERAPEUTICS 1, 10 (2015); Michael
Lynskey & Wayne Hall, The Effects of Adolescent Cannabis Use on Educational
Attainment: A Review, 95 ADDICTION 1621 (2000); Madeline H. Meier, et al.,
Persistent Cannabis Users Show Neuropsychological Decline from Childhood to
Midlife, 109 PROC. NAT’L ACAD. SCI. E2657 (2012); Bridget Onders et al.,
Marijuana Exposure Among Children Younger than Six Years in the United
States, 55 CLINICAL PEDIATRICS 428 (2016); Edmund Silins et al., Young Adult
Sequelae of Adolescent Cannabis Use: An Integrative Analysis, 1 LANCET
PSYCHIATRY 286 (2014); Nadia Solowij et al., Verbal Learning and Memory in
Adolescent Cannabis Users, Alcohol Users and Non-Users, 216
PSYCHOPHARMACOLOGY 131 (2011); Joan E. Zweben & Judith Martin, Physician
Recommendations for Marijuana: Special Populations and Contraindications, in
Sanford & Avoy, supra note 12, at 91, 94; Valérie Wolff et al., Cannabis Use,
Ischemic Stroke, and Multifocal Intracranial Vasoconstriction: A Prospective
Study in 48 Consecutive Young Patients, 42 STROKE 1778 (2011); see generally
Volkow, supra note 28, at 2219 (“The regular use of marijuana during adolescence
is of particular concern, since use by this age group is associated with an
increased likelihood of deleterious consequences . . . .” (footnote and citation
omitted); id. at 2220 (noting that “[a]ltered brain development,” “[p]oor
educational outcome,” “cognitive impairment,” and “[d]iminished life
satisfaction” are “strongly associated with initial marijuana use early in
adolescence”). Recently, an eleven-month old infant died from what physicians
surmised (because no other cause was found) was marijuana-induced myocarditis
(inflammation of the heart muscle). See Thomas M. Nappe & Christopher O.
Hoyte, Pediatric Death Due to Myocarditis After Exposure to Cannabis, 1
CLINICAL PRAC. & CASES EMERGENCY MED. 166 (2017); see also Andrew Blake,
Marijuana Overdose Killed 11-Month-Old Infant, Doctors Claim, WASH. TIMES
(Nov.
16,
2017),
https://www.washingtontimes.com/news/2017/nov/16/
marijuana-overdose-killed-11-month-old-infant-doct/; Ellie Silverman, The Truth
Behind the ‘First Marijuana Overdose Death’ Headlines, WASH. POST (Nov. 17,
2017), https://www.washingtonpost.com/news/to-your-health/wp/2017/11/17/thetruth-behind-the-first-marijuana-overdose-death/?hpid=hp_hp-more-top-stories
_marijuana-death-555am%3Ahomepage%2Fstory&utm_term=.0a10a86cd9db.
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American Academy of Ophthalmology, the National Institute
for Drug Abuse, and others—have noted those harms and
agree that minors should not use cannabis.31
Of particular concern in the case of minors is the
neurophysiological effect that THC has on the juvenile brain.
According to one textbook, “[g]rowing evidence suggests that
marijuana use during adolescence affects normal
physiological maturation processes in the frontal cortex.” 32
Those adverse effects could be a contributory factor to future
problems with executive functioning and impulse control,
including substance use disorders.33
31. See, e.g., U.S. FOOD & DRUG ADMIN., FDA AND MARIJUANA (Feb. 28, 2017)
(“The FDA has not approved marijuana as a safe and effective drug for any
indication.”); NAT’L INST., MARIJUANA, supra note 22, at 17; AM. ACAD.
OPHTHALMOLOGY, COMPLEMENTARY THERAPY ASSESSMENT: MARIJUANA IN THE
TREATMENT OF GLAUCOMA 1 (2014); AM. CANCER SOC’Y, MEDICAL USE OF
MARIJUANA: ACS POSITION 3 (2013); AM. MED. ASS’N HOUSE OF DELEGATES,
REPORT OF REFERENCE COMMITTEE K 6–7 (2014); AM. PSYCHIATRIC ASS’N, POSITION
STATEMENT ON MARIJUANA AS MEDICINE (Dec. 2013); HALL & PACULA, supra note
28, at 214–17 (discussing adverse effects to cells and to immunological,
reproductive, cardiovascular, respiratory, and gastrointestinal systems, as well
as the risk of precipitating psychosis in vulnerable individuals); Ryan &
Ammerman, Counseling Parents and Teens, supra note 28, at e2; Volkow et al.,
supra note 28; cf. AM. EPILEPSY SOC’Y, AES POSITION ON MEDICAL MARIJUANA
(Mar. 21, 2016) (“The anecdotal reports of positive effects of the marijuana
derivative cannabidiol (CBD) for some individuals with treatment-resistant
epilepsy give reason for hope. However, we must remember that anecdotal
reports alone are not sufficient to support treatment decisions.”). Infrequent or
“experimental” marijuana use, however, generally is a different matter. There
might be an exception for use of high-potency THC, low cannabidiol content
marijuana, colloquially known as “skunk.” Marijuana with a very high THC:CBD
ratio can give rise to psychotic episodes. See Marta Di Forti et al., supra note 29,
at 236. A novice using such cannabis might have such an episode from his first
use. A child, almost certainly.
32. KOOB ET AL., supra note 11, at 287. “Executive functioning” means “the
ability to organize thoughts and activities, prioritize tasks, manage time, and
make decisions.” Id. at 286. Marijuana use can also harm children in utero. See,
e.g., WHO REPORT, supra note 29, at 28 (citations omitted) (“[A]ccumulating
evidence suggests that prenatal cannabis exposure may interfere with normal
development and maturation of the brain. Children exposed to cannabis in utero
demonstrate impaired attention, learning and memory, impulsivity and
behavioural problems and a higher likelihood of using cannabis when they
mature . . . .”).
33. See KOOB ET AL., supra note 11, at 287.

2018]

MARIJUANA EDIBLES

329

Since the 1960s, scientists have discovered that the
human brain maturation process extends into a person’s
mid-twenties as the brain creates neurons while pruning and
reorganizing neural pathways for efficient use by adults.34
The process of ongoing development is particularly
important in connection with the prefrontal cortex, the
region responsible for higher mental functions such as
reasoning, judgment, and decision-making. Given the labile
state of the adolescent brain, and depending on the dose and
frequency of use, a minor’s use of a psychoactive substance
like THC is likely to have adverse physical and mental effects
that would not occur in an adult or, even if they did, would
not be present to the same degree.35 The result hampers
34. See, e.g., Seth Ammerman et al., The Impact of Marijuana Policies on
Youth: Clinical, Research, and Legal Update, 135 PEDIATRICS E769, E771 (2015)
[hereinafter Ammerman et al., Marijuana Policies]; Bossong & Niesink, supra
note 30, at 372–77; Madras, supra note 12, at 14–15; Ryan & Ammerman,
Counseling Parents and Teens, supra note 28, at E2. In fact, the prefrontal lobe
region is the last area of the adolescent brain to undergo the neuromaturational
development resulting from the extension of neurons into new regions and the
pruning of unnecessary connections. See, e.g., Ammerman et al., Marijuana
Policies, supra, at E770; Bossong & Niesink, supra, at 373.
35. See Kalant, supra note 12, at 394 (noting “the possibility that during brain
maturation in adolescence, heavy exposure to cannabis might prevent the growth
of axons and the establishment of large numbers of synaptic connections that
normally accompany experience and learning”) (citations omitted); id. (“the
results of MRI studies of the brains of late teen-aged males who had used
marijuana heavily throughout adolescence” revealed a “smaller brain size and
thinner cortex in early heavy users than in age-matched users who did not begin
until after 17”); Ammerman et al., Marijuana Policies, supra note 34, at E770
(noting adverse “effects of marijuana use on hippocampal, prefrontal cortex, and
white matter volume” in minors); Sarah D. Lichenstein et al., Nucleus Accumbens
Functional Connectivity at Age 20 Is Associated with Trajectory of Adolescent
Cannabis Use and Predicts Psychosocial Functioning in Young Adulthood, 112
ADDICTION 1961 (2017); Meier et al., supra note 30 (noting that the “results of
several studies showing executive functioning or verbal IQ deficits among
adolescent-onset but not adult-onset chronic cannabis users . . . as well as studies
showing impairment of learning, memory, and executive functions in samples of
adolescent cannabis users”) (endnotes omitted); Volkow et al., supra note 28, at
2220 (“The brain remains in a state of active, experience-guided development
from the prenatal period through childhood and adolescence until the age of
approximately 21 years. . . . The negative effect of marijuana use on the
functional connectivity of the brain is particularly prominent if use starts in
adolescence or young adulthood, which may help to explain the finding of an
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development of higher-order mental states necessary for
mature reasoning and planning.36
Those adverse effects can manifest themselves in several
ways. As the American Academy of Pediatrics has noted,37
numerous published studies have established the harmful
short- and long-term effects suffered by minors—from
infants to adolescents—resulting from unwitting THC
consumption or heavy, long-term marijuana use. Aside from
intoxication, the range of effects include: decreased
concentration, attention span, diminished judgment,
reaction time, tracking ability, and problem-solving skills,
which hampers driving ability; short-term memory loss;
respiratory deficits or arrests; and increased risk of mental
association between frequent use of marijuana from adolescence into adulthood
and significant declines in IQ. The impairments in brain connectivity associated
with exposure to marijuana in adolescence are consistent with preclinical
findings that the cannabinoid system plays a prominent role in synapse
formation during brain development.”) (footnotes omitted). Heavy or long-term
cannabis use appears to be a critical factor. See Madeleine H. Meier, Associations
Between Adolescent Cannabis Use and Neuropsychological Decline: A
Longitudinal Co-Twin Control Study, 113 ADDICTION 257 (2017) (concluding that
short-term marijuana use does not appear to cause IQ decline or impair executive
function); Wendy Swift et al., Are Adolescents Who Moderate Their Cannabis Use
at Lower Risks of Later Regular and Dependent Cannabis Use?, 104 ADDICTION
806 (2009) (answering the question posed in title as “Yes”).
36. See KOOB ET AL., supra note 11, at 285 (“The adolescent period represents
a critical phase of development, characterized by specific progressive
neurobiological maturational processes in the prefrontal cortex that includes
myelination and synaptic pruning. This period of maturation also involves the
rearrangement of key neurotransmitter systems, such as glutamate, γaminobutyric acid, dopamine, and Endocannabinoid systems in the frontal
cortex. Changes in these systems are believed to support the emergence of adult
cognitive processes. Over the course of adolescence and early adulthood,
individuals show normative growth in planning, preference for delayed rather
than immediate rewards, resistance to peer pressure, and impulse control. Many
of the brain regions that are undergoing these developmental changes may be
particularly affected by alcohol and marijuana use.”). Of course, the science on
this subject is not on a par with Newton’s First Law of Motion; there are studies
to the contrary as well. See, e.g., Ileana Pacheco-Colon et al., Is Cannabis Use
Associated with Various Indices of Motivation Among Adolescents?, 52 SUBST. USE
& MISUSE 1 (2017).
37. See Ammerman et al., Marijuana Policies, supra note 34, at E670; Ryan
& Ammerman, Counseling Parents and Teens, supra note 28, at E2.
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health disorders such as psychosis and depression.
Adolescent marijuana use is also associated with a lower
probability of faring well in school—including a greater
likelihood of being suspended or dismissed from school, a
higher probability of work dissatisfaction and failure—being
fired and collecting welfare, later marijuana dependence, use
of other illegal drugs, and suicide attempts.38 Finally,
someone who begins long-term use during adolescence is
likely to suffer negative effects on executive functioning that
do not recover upon reaching the age of majority, even if use
is later discontinued.39 The number of minors affected
multiplies the societal implications of those individual
harms. The associated harms are troubling too. As two
commentators noted, “the availability of child-friendly
edibles could increase the probability of initiation to
marijuana use, reduce the average age of initiation, and
increase the frequency and intensity of use among users of
all ages.”40
38. See, e.g., Budney et al., in Ruiz & Strain, supra note 25, at 227 (“Crosssectional and longitudinal studies have reported a clear association between
chronic cannabis use and impaired psychological functioning. In particular,
cannabis has been associated with poorer life satisfaction, increased mental
health treatment and hospitalization, higher rates of depression, anxiety
disorders, suicide attempts, and conduct disorder.”) (endnote omitted); Brook et
al., supra note 29, at 87–88; Silins et al., supra note 29, at 286. Other harms, such
as comas, are also possible but are rare. See, e.g., WHO REPORT, supra note 29,
at 48–50.
39. See, e.g., NAT’L ACAD. OF SCI., ENG’G, & MED., THE HEALTH EFFECTS OF
CANNABIS AND CANNABINOIDS: THE CURRENT STATE OF EVIDENCE AND
RECOMMENDATIONS FOR RESEARCH 18 (2017); Madeline H. Meier et al., Persistent
Cannabis Users Show Neuropsychological Decline from Childhood to Midlife, 109
PROC. NAT’L ACAD. SCI. E2657 (2012); Henrietta Szutorisz & Yasmin L. Hurd,
High Times for Cannabis: Epigenetic Imprint and Its Legacy on Brain and
Behavior, 85 NEUROSCIENCE & BIOBEHAVIORAL REVS. 93, 98–99 (2018) (“The
relationship between cannabis use and neuropsychiatric vulnerability is clearly
complex, but the limited data accrued to date in this fast growing field already
documents that early exposure during one’s lifetime leaves a long-term epigenetic
memory mark which sets a legacy even onto future generations.”).
40. MacCoun & Mello, supra note 8, at 990. Cf. ROOM ET AL., supra note 2, at
15 (“The health and psychological effects of regular cannabis use are not as well
understood as those of alcohol and tobacco, but epidemiological research over the
past decade has provided evidence that it can have adverse effects on some users,
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States that have liberalized their marijuana laws have
attempted to avoid those dangers by, inter alia, limiting
recreational sales to adults.41 Unfortunately, experience has
taught that such legal restrictions do not prevent children—
to say nothing of adolescents—from finding the drug in their
parents’ supply or obtaining it elsewhere and mistakenly
consuming it, or being deliberately tempted to do so.42
According to Sgt. Jim Gerhardt of the Colorado Drug
Investigators Association, “[y]ou have little kids that
accidentally get into this stuff; they don’t know any better.”43
He also said that others, such as a neighbor, a friend, a
schoolmate, a babysitter, or another family member, could
unwittingly give a child candy not realizing what it is. “Those
particularly those who initiate use in adolescence and use more than weekly for
years during young adulthood.”). That is troublesome because “[c]annabis use in
the USA typically begins in the mid to late teens, and is most prevalent in the
early 20s” and because “about 10% of those who ever use cannabis become daily
users,” with “another 20% to 30% use cannabis weekly . . . .” Id. at 4–5. “Among
those who begin to use in their early teens, the risk of developing problem use
may be as high as one in six . . . .” Id. at 5.
Two other points are worth noting. First, adolescents who drive after using
marijuana are at greater risk of being in a motor vehicle accident, particularly if,
as is often the case, they also consume alcohol. See, e.g., KOOB ET AL., supra note
11, at 283–84; ROOM ET AL., supra note 2, at 15, 17–19; Larkin, Drugged Driving,
supra note 4, at 473–80 & nn.87–109. Second, juveniles who begin heavy, longterm marijuana use can become addicted to it. See Peters & Mechoulam, supra
note 12, in Stanford & Avoy, supra note 12, at 38–39 (describing the neurobiology
of addiction); Volkow et al., supra note 28, at 2220 (“[E]arly and regular
marijuana use predicts an increased risk of marijuana addiction, which in turn
predicts and increased risk of the use of other illicit drugs. As compared with
persons who begin to use marijuana in adulthood, those who begin to use in
adolescence are approximately 2 to 4 times as likely to have symptoms of
cannabis dependence within 2 years after first use.”) (footnotes omitted).
41. MacCoun & Mello, supra note 8, at 989. Minors can use marijuana
medically only with physician approval and parental consent. See, e.g., COLO.
CONST. art. XVII, § 14(6).
42. See Barrus et al., supra note 11, at 4 (“Not unexpectedly, ingestion was
the most common route of exposure resulting in most of these [pediatric]
emergency room visits.”).
43. Jeff Rossen & Jovanna Billington, Rossen Reports Update: Edible
Marijuana that Looks Like Candy Is Sending Kids to the ER, TODAY (Sep. 16,
2017, 7:41 AM), https://www.today.com/parents/edible-marijuana-looks-candysending-kids-er-t94486.
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accidental issues are on the rise, and it’s a big problem.”44 In
the words of Dr. Robert Glatter, a New York City emergency
room physician, “[t]his is extremely dangerous.”45
44. Id.
45. Id.; see, e.g., Kosa et al., supra note 15, at 58 (noting that a 2016 study
found that “annual Regional Poison Center pediatric marijuana cases increased
more than fivefold from 2009 to 2015, and edibles were responsible for 52% of the
exposures.”); MacCoun & Mello, supra note 8, at 990 (“Whether through
deliberate acquisition or unknowing consumption, these child-friendly edibles
increase minors’ risk of exposure to and experimentation with marijuana.”);
Derek Murray et al., When the Grass Isn’t Greener: A Case Series of Young
Children with Accidental Marijuana Ingestion, 18 CAN. J. EMERG. MED. 480
(2016); Nathan et al., supra note 5, at 1746 (“[C]annabis prohibition for adults
does not prevent underage use. For decades, preventive education reduced the
rates of alcohol and tobacco use by minors, whereas underage marijuana use has
fluctuated despite its prohibition for adults. Since the 1970s, 80% to 90% of those
aged 18 years have consistently reported easy access to the drug.”) (footnote
omitted); Wang et al., Colorado Study 2009–2015, supra note 15; Wang et al.,
Multistate Study 2005–2011, supra note 14, at 686 (noting an increase in the rate
of pediatric exposure to marijuana from 2005 to 2011 in states that had passed
marijuana legislation); George Sam Wang et al., Pediatric Marijuana Exposures
in a Medical Marijuana State, 167 JAMA PEDIATRICS 630 (2013); 3 Warren
Middle Schoolers Hospitalized After Eating Marijuana-Laced Cookie Crisp, CBS
DETROIT (Nov. 15, 2017), http://detroit.cbslocal.com/2017/11/15/students-eatmarijuana-edibles/ (“Warren Police Commissioner Bill Dwyer said officers were
called to the Michigan Math and Science Academy on Dequindre Road,
Wednesday morning, after three young girls had eaten Cookie Crisp cereal coated
in marijuana oil. . . . ‘When our officers arrived, the principal and parents advised
the officers that three 8th grade female students had been transported to St. John
Oakland Hospital after complaints of feelings dizzy and light-headed,’ . . . .”); 11
Teens Ill After Eating Drug-Laced Gummy Bears, ABC NEWS (July 7, 2017),
http://abc7chicago.com/news/11-teens-ill-after-eating-drug-laced-gummybears/2192901/; Alaska High School Students’ Parents Turn Them in for Selling
Pot Gummy Bears, ASSOCIATED PRESS (Dec. 8, 2017), http://www.thecannabist.co/
2017/12/08/alaska-high-school-students-marijuana-gummy-bears/94235/; Dan
Atkinson, THC-Laced Sweets Causing Concern, BOSTON HERALD (Oct. 31, 2017),
http://www.bostonherald.com/news/local_coverage/2017/10/thc_laced_sweets_ca
using_concern; Peter Burke, 2 Teens Treated after Ingesting Marijuana-Laced
Gummy Candies at School, ABC NEWS (Mar. 30, 2017), https://www.local10.com/
education/2-teens-ingest-marijuana-laced-gummy-candies-at-school; Bill Bird,
Teens Charged in Pot-Laced Gummy Bear Incident at Naperville North, CHI.
TRIBUNE (Feb. 9, 2017), http://www.chicagotribune.com/suburbs/napervillesun/crime/ct-nvs-naperville-more-gummy-arrests-st-0212-20170210-story.html;
Jessica Chen, One Arrested after Marijuana Gummy Bears Sicken Chula Vista
Students, ABC NEWS (Apr. 27, 2017), https://www.10news.com/news/onearrested-after-marijuana-gummy-bears-sickens-chula-vista-students; K.J. Dell
‘Antonia, When Marijuana Looks Like Candy, Not Drugs, N.Y. TIMES (Feb. 11,
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2014), https://parenting.blogs.nytimes.com/2014/02/11/when-marijuana-looks-lik
e-candy-not-drugs/; Keith Farner, GCPS Investigating Edible Medical Marijuana
Incident at Middle School, Jan. 20, 2017, GWINNETT DAILY POST (Jan. 20, 2017),
http://www.gwinnettdailypost.com/local/gcps-investigating-edible-medical-marij
uana-incident-at-middle-school/article_14237fd4-fca8-577e-9b59-50b52ddaebd
5.html; Carla Field, Students Eat THC-Laced Gummy Bears; 1 Taken to Hospital,
Another Arrested, WYFF GREENVILLE (Mar. 21, 2017) http://www.wyff4.com/
article/students-eat-thc-laced-gummy-bears-1-taken-to-hospital-another-arreste
d/9163208; Gummy Candy Found at Florida High School Was Laced with THC,
JUST BELIEVE RECOVERY CTR., https://justbelieverecovery.com/gummy-candy-thc/
(last accessed Dec. 9, 2017); Sheena Jones & Madison Park, Sickened Students
Suspect Marijuana-Laced Gummy
Bears,
CNN (Dec.
8,
2016),
http://www.cnn.com/2016/12/07/us/students-sick-gummy-bears/index.html
(“Several [14, in fact] high school students were taken to a local hospital after
eating gummy bears some said may have been laced with marijuana.”); Dal Kalsi,
Police: Hillcrest High Student Hospitalized, Another Arrested After Eating
Marijuana-Laced Gummy Bears, FOX CAROLINA (Apr. 18, 2017),
http://www.foxcarolina.com/story/34964042/police-hillcrest-high-student-arreste
d-after-distributing-marijuana-laced-gummy-bears-at-school; Seth Klamann,
Parents Ask Casper School Officials to Consider Drug Testing, CASPER STAR
TRIBUNE (Mar. 8, 2017), http://trib.com/news/local/education/parents-ask-casperschool-officials-to-consider-drug-testing/article_3195b84f-5820-5dae-a1c5-57001
0591694.html (“Natrona County High School students eating marijuana-laced
gummy bears on a school bus prompted a group of parents to approach school
board members about implementing a drug testing policy in the district.”); Lance
Knobel, Two Berkeley High Students Hospitalized after Eating Marijuana
Edibles, BERKELEYSIDE (Dec. 2, 2016), http://www.berkeleyside.com/2016/
12/02/two-berkeley-high-students-hospitalized-after-eating-marijuana-edibles/
(“[Berkeley High School Principal Sam Pasarow] said parents should remind
students to never accept food from other students without knowing their origin.
‘Edible products are particularly dangerous as they can include a range of
substances and unclear dosages and drug potency,’ he wrote.”); Abby Phillip,
More and More Little Kids are Finding Mom and Dad’s (Legal) Marijuana Stash,
WASH. POST (June 9, 2015), https://www.washingtonpost.com/news/wonk/
wp/2015/06/09/more-and-more-little-kids-are-finding-mom-and-dads-legal-marij
uana-stash/?noredirect=on&utm_term=.a0d87a0044cf (“In the places where
marijuana is legal, more and more children are being accidentally exposed to
their parents’ drugs, a new study found. . . . [B]etween 2006 and 2013, the rate of
exposure increased by 147.5 percent. . . . Accidental ingestions, which account for
a whopping 75 percent of cases, are much more likely with the growing
availability of marijuana edibles. Most of these kids are probably ingesting
marijuana accidentally—on account of their natural curiosity and the fact that
the products themselves can taste like treats, researchers said. A majority of the
children exposed to marijuana were 3 years old or younger, according to the
study.”); Kristine Phillip, A Fifth Grader Thought She Brought Gummy Bears to
School. They Were Laced with Marijuana, WASH. POST (Jan. 21, 2018) (on file
with author) (“A 9-year-old student in New Mexico gave fellow students
gummies—only to realize later they were not ordinary candies. The candies had
apparently been laced with [THC] the chemical responsible for how marijuana
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Proof can be seen in the increase in calls to poison control
centers. From 2005 through 2011, there was no increase in
the call rate to poison control centers in states where
marijuana use was illegal, but there was a thirty percent
increase in the number of calls in states that had
decriminalized marijuana use.46 The rate of exposure is also
increasing. There was no change in the rate between 2000
and 2006, but the rate increased by 147.5% from 2006
through 2013.47 The number of reports is also significant:
1,969 children under six years old were reported for
marijuana exposure to poison control centers from 2000
through 2013.48 More than seventy-five percent of the
children exposed to marijuana were under three years old.49
One study noted that “[s]tates that decriminalized medical
marijuana have shown an increase in emergency department
(ED) visits and regional poison center (RPC) cases for
unintentional pediatric marijuana exposures.”50 Colorado, in
particular, saw a thirty-four percent increase in marijuana
exposure cases between 2009 and 2015—an amount greater
affects the brain and were being used by the student’s parents as medical
marijuana.”); Shira Schoenberg, “From Gummy Bears to Open Doors, Inspections
Identify Problems at Massachusetts Medical Marijuana Dispensaries,”
MASSLIVE.COM (Jan. 19, 2018), http://www.masslive.com/politics/index.ssf/
2018/01/from_gummy_bears_to_open_doors.html); Rick Wilking, Reuters, Bad
Munchies: Boy Sent to Hospital after Eating Pot-Laced Gummy Bears on School
Bus, RT QUESTION MORE (Jan. 13, 2017) https://www.rt.com/usa/373363marijuana-gummy-bears-schoolbus/; Lyndsay Winkley, Eighth-Grader Sold PotLaced Gummy Bears to Fellow Students, Authorities Say, L.A. TIMES (Apr. 27,
2017),
http://www.latimes.com/local/lanow/la-me-ln-marijuana-gummy-bears20170427-story.html. Even adults can accidentally consume THC-infused food.
See Barrus et al., supra note 11, at 7 (“Reports of inadvertent ingestion of
cannabis edibles by adults are widespread. For example, a group of preschool
teachers in California experienced nausea, dizziness, headache, and other
symptoms after consuming brownies containing cannabis. One of the teachers
had purchased the brownies from a sidewalk vendor and placed them in the
breakroom . . . .”).
46. Wang et al., Multistate Study 2005–2011, supra note 14, at 686.
47. Onders, supra note 30, at 430.
48. Id.
49. Id. at 430, 432.
50. Wang et al., Colorado Study 2009–2015, supra note 15, at 2.
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than what occurred in any other state.51 The vast majority of
exposures were edibles; they accounted for seventy-five
percent of the exposures.52 That result is particularly likely
when edibles are shaped and colored to mimic candies
already familiar to children or infants who are not yet
intellectually capable of understanding the risks of
consuming edibles or parental warnings about the harms of
marijuana use.53
Of course, children are not the only minors who can
consume marijuana. Marijuana, including cannabis obtained
for medical purposes, has been diverted to adolescents, who
may use edibles to disguise their marijuana use.54 Smoking
marijuana leaves a signature aroma; ingesting marijuana
does not. The result is that adolescents may use edibles,

51. See id. at 4; see also John Ingold, Children’s Hospital Sees Surge in Kids
Accidentally Eating Marijuana, DENVER POST (Oct. 2, 2016, 4:01 PM),
http://www.denverpost.com/2014/05/21/childrens-hospital-sees-surge-in-kidsaccidentally-eating-marijuana/ (“The number of children coming into Colorado’s
largest pediatric emergency department after accidentally eating marijuana is
on pace to more than double last year’s total. . . . Most of the children admitted
are between 3 and 7 years old . . . .”).
52. See Monte et al., supra note 5, at 242 (“The most concerning health effects
have been among children. The number of children evaluated in the ED for
unintentional marijuana ingestion at the Children’s Hospital of Colorado
increased from 0 in the 5 years preceding liberalization to 14 in the 2 years after
medical liberalization. This number has increased further since legalization; as
of September 2014, 14 children had been admitted to the hospital this year, and
7 of these were admitted to the intensive care unit. The vast majority of intensive
care admissions were related to ingestion of edible THC products.”); Onders,
supra note 30, at 430, 432; Wang et al., Multistate Study 2005–2011, supra note
14, at 684.
53. Wang et al., Multistate Study 2005–2011, supra note 14, at 688 (“These
edible products are often indistinguishable from non-marijuana-containing food
products, are highly attractive and palatable to children, and can contain very
high amounts of [THC.]”) (footnote omitted).
54. Wang et al., Multistate Study 2005–2011, supra note 14, at 684. Kris
Kirschner, “Weed Candy” Just One Way Teenagers Hide Marijuana Use, WTHR
(Apr. 14, 2016, 10:30 PM), https://www.wthr.com/article/weed-candy-just-oneway-teenagers-hide-marijuana-use (“Across the country, police agencies are
reporting evidence of a new way to disguise illegal drugs, by wrapping them in
familiar and innocent looking covers. ‘Weed candy’ is marijuana cooked into hard
candy—and it’s beginning to make its way into Indiana.”).
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particularly ones disguised as anodyne candies, to start
down a path that could lead to the harms resulting from
prolonged use.
There are additional risks associated with use of
marijuana by teenagers. They may be aware that they are
consuming marijuana, but unaware of the considerable delay
between ingestion and the psychoactive effect that THC
produces or of the amount of THC that they can consume in
a single edible. The result is that they may overconsume the
amount of marijuana necessary to produce the hoped-for
euphoria and, instead, have an adverse reaction.55
Keep in mind that the marijuana grown and sold today
is not your granddaddy’s ganja. Current products have a
greater THC content than what was used from the 1960s
through the 1980s, perhaps due to the effect of competition.56

55. Cf. BRUCE BARCOTT, WEED THE PEOPLE: THE FUTURE OF LEGAL MARIJUANA
AMERICA 272 (2015) (“It [viz., overconsumption] was a problem because
industry and state officials miscalculated their dosing rules. A single package of
recreational edibles in Colorado could contain no more than 100 milligrams of
THC. That meant one cookie in its own package might max out at 100 milligrams.
But the state considered a ‘serving size’ to be 10 milligrams. So a single cookie
might constitute 10 servings. Who looks at a single cookie and thinks, Ten
servings? Nobody, that’s who.”) (emphasis in original).
IN

56. See, e.g., Budney et al., in Ruiz & Strain, supra note 25, at 216 (the
potency of marijuana increased by sixty percent over 2000–2010); ROOM ET AL.,
supra note 2, at 6 (noting that some varieties of marijuana (Sinsemilla, also
known as skunk and Netherweed) may have THC content as high as 20 percent,
that hashish (dried cannabis resin and crushed plants) has a THC content in the
range of 2–20 percent, and that hash oil (an oil-based extract of hashish) has a
THC content of 15–50 percent); id. at 39–40; Wayne Hall & Louisa Degenhardt,
High Potency Cannabis: A Risk Factor for Dependence, Poor Psychosocial
Outcomes, and Psychosis, 350 BR. MED. J. 1205 (2015); Eric L. Sevigny et al., The
Effects of Medical Marijuana Laws on Potency, 25 INT’L J. DRUG POL’Y 308, 309
(2014) (“Although direct empirical evidence is limited, insider and journalistic
accounts suggest that [medical marijuana laws]—and the medical marijuana
industry built up around them—have greatly enhanced the development and
diffusion of high-potency cannabis cultivars and sophisticated techniques of
production.”); Volkow et al., supra note 29, at 2222 (“The THC content, or potency,
of marijuana, as detected in confiscated samples, has been steadily increasing
from about 3% in the 1980s to 12% in 2012. . . . This increase in THC content
raises concerns that the consequences of marijuana use may be worse now than
in the past and may account for the significant increases in emergency
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One study estimates that the potency nearly tripled between
1990 and 2010 from 3.4% to 9.6%,57 although other studies
put the number even higher, up to 20%.58 Cannabis oil
extracts can be as high as 80%.59 The THC content of edibles
can be especially high.60 In fact, the marijuana industry has
developed a synthetic crystalline form of THC that is 99.9%
pure.61 The increase in potency over time persuaded NIDA
Director Dr. Volkow to question “the current relevance of the
findings in older studies on the effects of marijuana use,
especially studies that assessed long-term outcomes.”62
department visits by persons reporting marijuana use . . . and the increases in
fatal motor-vehicle accidents.”) (footnotes omitted). It is also important to note
that the relatively low ratio of THC to cannabidiol (CBD) in the native plant may
have protected earlier generations of users from severe adverse effects. Research
shows that THC administered alone can have a dramatic adverse effect on critical
brain biology. The theory is that CBD attenuates the effects of THC in brain
tissue. See ROOM ET AL., supra note 2, at 15; Di Forti et al., supra note 29, at 236;
M.A. El Sohly et al., Changes in Cannabis Potency Over the Last Two Decades
(1995–2014): Analysis of Current Data in the United States, 79 BIOLOGICAL
PSYCHIATRY 613, 617 (2016). Even if adults can titrate the amount of high-content
THC they consume, see ROOM ET AL., supra note 2, at 40, children cannot.
57. Sevigny et al., supra note 56, at 308, 315 (noting that marijuana potency
“significantly increases by about one percentage point over time” in states with
medical marijuana laws).
58. See DSM-5, supra note 28, at 511 (marijuana potency ranges from 1–15
percent, hashish from 10–20 percent; “During the past two decades, a steady
increase in the potency of seized cannabis has been observed.”); HUDAK, supra
note 15, at 17–18; IVERSEN, supra note 12, at 10 (estimating potency at 10–20
percent); Kleber & DuPont, supra note 14, at 565 (estimating up to 20 percent).
59. See Beau Kilmer & Rosalie Liccardo Pacula, Understanding and Learning
from the Diversification of Cannabis Supply Laws, 112 ADDICTION 1128, 1131
(2016).
60. Onders et al., supra note 30, at 432.
61. See Anna Wilcox, THC-A Crystalline: The World’s Strongest Hash with
99.99% THC, HERB (Mar. 29, 2017), https://herb.co/2017/03/29/thc-a-crystalline/.
A 99% standard is used in Dronabinol, marketed as Marinol, an FDA-approved
pill-form drug with an isolated THC cannabinoid that is approved for
chemotherapy-induced nausea. See Dronabinol: Pharmacology and Biochemistry,
NAT’L CTR. BIOTECHNOLOGY INFO., https://pubchem.ncbi.nlm.nih.gov/compound/
Dronabinol#section=Pharmacology-and-Biochemistry (last visited Mar. 21,
2018).
62. Volkow et al., supra note 28, at 2222. Another consideration is the
inconsistency in the THC concentration within some products, which can lead
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Those problems are not isolated or transient ones. On the
contrary, at least 60% of new drug initiates are younger than
eighteen years old, the age of onset is declining, daily use of
marijuana by juveniles is at its highest level in thirty years,
marijuana use exceeds nicotine use, and 44.5% of twelfthgraders report having used cannabis, with 6% reporting
daily use during the preceding thirty days.63 Juvenile
consumption of THC is a serious public health and policy
issue.
III. THE NEED FOR THE FDA TO PROTECT MINORS FROM
MARIJUANA EDIBLES
A. State Regulatory Efforts
States authorizing recreational marijuana use, such as
Colorado, have sought to prevent those problems from
occurring by regulating the manufacture, packaging, and
distribution of edible marijuana.64 For example, four states
currently have operational recreational marijuana
programs. Each one forbids the manufacture and packaging
of products that could appeal to children and requires that
edibles be sold in child-resistant packaging.65 The level of
some users to overconsume a suggested service portion. See, e.g., Kosa et al.,
supra note 15, at 58.
63. See BABOR ET AL., supra, note 8, at 105 (“[A]dolescence is the period of life
in which drug use is most likely to begin.”); Budney et al., in Ruiz & Strain, supra
note 25, at 216 (rates of use and incidence of cannabis use disorder increased
during 1995–2010; marijuana use also initiating at a younger age); Lichenstein
et al., supra note 35, at 1961; Madras, supra note 12, at 12–13.
64. See Barrus et al., supra note 11, at 9–10; Jacob T. Borodovsky & Alan J.
Budney, Legal Cannabis Laws, Home Cultivation, and Use of Edible Cannabis
Products: A Growing Relationship, 50 INT’L J. DRUG POL’Y 102, 103 (2017);
Camille Gourdet et al., How Four U.S. States Are Regulating Recreational
Marijuana Edibles, 43 INT’L J. DRUG POL’Y 83, 84–89 (2017); Kosa et al., supra
note 15, at 58–64. In 2016, California, Maine, Massachusetts, and Nevada also
legalized recreational marijuana use, but, other than California, those programs
have not yet become operational as of the date of this Article. See Gourdet et al.,
supra, at 83.
65. See, e.g., COLO. CODE REGS. § 212-1-1001.5(C) (2017) (prohibiting medical
marijuana businesses from packaging items “in a manner that specifically
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targets individuals under the age of 21, including but not limited to, cartoon
characters or similar images.”); id. § 212-1-1001.5(H) (forbidding the use of the
word “candy” or “candies” on medical marijuana products); id. §§ 212-1-1004.5(A),
212-1-1006(A), 212-1-1007(A) (requiring medical marijuana centers to package
their products in child-resistant containers); id. §§ 212-2-1001 to 212-2-1007.5
(requiring the same packaging and labeling requirements for retail or
recreational marijuana); WASH. ADMIN. CODE § 314-55-105(7) (2017) (“Marijuanainfused products and marijuana concentrates meant to be eaten, swallowed, or
inhaled, must be packaged in child resistant packaging in accordance with Title
16 C.F.R. 1700 of the Poison Prevention Packaging Act or use standards specified
in this subsection. Marijuana-infused product in solid or liquid form may be
packaged in plastic four mil or greater in thickness and be heat sealed with no
easy-open tab, dimple, corner, or flap as to make it difficult for a child to open
and as a tamperproof measure. Marijuana-infused product in liquid form may
also be sealed using a metal crown cork style bottle cap. Marijuana-infused solid
edible products. If there is more than one serving in the package, each serving
must be packaged individually in childproof packaging (see WAC 314-55-105(7))
and placed in the outer package. Marijuana-infused liquid edible products. If
there is more than one serving in the package, a measuring device must be
included in the package with the product. Hash marks on the bottle do not qualify
as a measuring device. A measuring cap or dropper must be included in the
package with the marijuana-infused liquid edible product.”); id. § 314-55-105(11)
(“All marijuana and marijuana products when sold at retail must include
accompanying material that is attached to the package or is given separately to
the consumer containing the following warnings: (a) ‘Warning: This product has
intoxicating effects and may be habit forming. Smoking is hazardous to your
health’; (b) ‘There may be health risks associated with consumption of this
product’; (c) ‘Should not be used by women that are pregnant or breast feeding’;
(d) ‘For use only by adults twenty-one and older. Keep out of reach of children’;
(e) ‘Marijuana can impair concentration, coordination, and judgment. Do not
operate a vehicle or machinery under the influence of this drug’; (f) Statement
that discloses all pesticides applied to the marijuana plants and growing medium
during production and processing.”); id. § 314-55-105(13) (“In addition to
requirements in subsection (10) of this section, labels affixed to the container or
package containing usable marijuana, or packaged marijuana mix sold at retail
must include: (a) Concentration of THC (total THC and activated THC-A) and
CBD (total CBD and activated CBD-A); (b) Date of harvest.”); id. § 314-55-105(14)
(“In addition to requirements in subsection (10) of this section, labels affixed to
the container or package containing marijuana-infused products meant to be
eaten or swallowed sold at retail must include: (a) Date manufactured; (b) Best
by date; (c) Serving size and the number of servings contained within the unit;
(d) Total milligrams of active THC, or Delta 9 and total milligrams of active CBD;
(e) List of all ingredients and major food allergens as defined in the Food Allergen
Labeling and Consumer Protection Act of 2004; (f) ‘Caution: When eaten or
swallowed, the intoxicating effects of this drug may be delayed by two or more
hours.’”); id. § 314-55-106(1) (“Marijuana-infused products meant to be eaten or
swallowed sold at retail must be labeled on the principal display panel or front of
the product package with the ‘not for kids’ warning symbol created and made
available in digital form to licensees without cost by the Washington poison
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success those states have had in keeping marijuana out of
the hands of minors, according to one study, “remains an
open, and somewhat controversial, question.”66
Additional steps could be taken to prevent access by
minors.67 Colorado recently took one such step by forbidding
the sale of any edible product in a form that resembles an
animate creature.68 Of course, there are numerous other
shapes that children easily recognize, such as a train, a car,
a flower, or a classic cuboidal shaped candy bar. The new
Colorado regulation, therefore, is an incomplete remedy.69 A
center (WPC). The warning symbol may be found on the WPC’s web site. (a) The
warning symbol must be of a size so as to be legible, readily visible by the
consumer, and effective to alert consumers and children that the product is not
for kids, but must not be smaller than three-quarters of an inch in height by onehalf of an inch in width; and (b) The warning symbol must not be altered or
cropped in any way other than to adjust the sizing for placement on the principal
display panel or front of the product package, except that a licensee must use a
black border around the edges of the white background of the warning symbol
image when the label or packaging is also white to ensure visibility of the warning
symbol.”); Barrus et al., supra note 11, at 10; Gourdet et al., supra note 64, at 87–
88.
66. Gourdet et al., supra note 64, at 87; Ben Tsutaoka et al., Edible Marijuana
Labeling and Packaging, 57 CLINICAL PEDIATRICS 227, 227–230 (2018)
(“Compliance of edible marijuana products to California label and packaging
requirements, set forth in AB-266, was poor. Ninety percent of the products were
labeled and in a tamper evident package; however, only one was in child-resistant
packaging. Colorado medical and retail marijuana statutes have provisions for
child-resistant packaging that conform to federal consumer product safety
regulations, that products are in opaque packaging so the product cannot be seen
and that the package is resealable if not single use; still pediatric exposures to
marijuana increased 5-fold from 2009 to 2015.”) (footnote omitted).
67. See MacCoun & Mello, supra note 8, at 990–91 (offering suggestions).
68. See COLO. CODE REGS. § 212-2-402(P) (forbidding edibles shaped as, or
containing characteristics of, humans, animals, or fruit); COLO. REV. STAT. § 1243.3-202(1)(b)(I) (2017) (authorizing the state marijuana licensing authority to
promulgate rules “as necessary for the proper regulation and control of the
cultivation, manufacture, distribution, and sale of medical marijuana and for the
enforcement of this article”).
69. See Kosa et al., supra note 15, at 58–59; Colorado Marijuana Bill:
Banning Weed-Infused Gummy Bears, WEEDLEX (July 4, 2016),
http://weedlex.com/colorado-marijuana-bill-banning-weed-infused-gummy-bears
(“While sweet edibles in the shape of bears and fish will be illegal to produce,
cannabis stars, leaves, and many other shapes that should have also fallen within
the purview of the law are not banned. This conveys that the House Bill 1436 is
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state could rely on state tort law to supplement regulations.
One theory would be that an edible resembling a traditional
form of candy would qualify as an “attractive nuisance,”
which would enable minors to recover damages from the
manufacturer and seller of the edible.70 Yet, insofar as the
blame lies with the parents for failing to prevent a minor
from accessing their “stash,” allowing, let alone encouraging,
minors to recover damages from their parents is hardly an
attractive way to encourage the latter to be careful.
B. Potential Federal Regulatory Efforts
The interesting questions are whether the federal
government can and should intervene to supplement the
states’ efforts to protect minors. To date, most of the debate
has focused on the issue of whether the Department of
Justice should prosecute marijuana dispensaries for
violating the federal drug laws. Those statutes do not contain
a medical or personal use exception,71 and, under the
Supremacy Clause, federal law trumps state law whenever
the two conflict.72 The result is that state marijuana
liberalization initiatives do not shield anyone from federal

a completely political action.”).
70. See MacCoun & Mello, supra note 8, at 989; see generally RESTATEMENT
(SECOND) OF TORTS § 339 (AM. LAW INST. 1965); PROSSER & KEETON ON TORTS § 59,
399-402 (W. Page Keeton et al. eds., 5th ed. 1984).
71. See, e.g., Gonzales v. Raich, 545 U.S. 1 (2005) (summarized supra note 7);
United States v. Oakland Cannabis Buyers’ Coop., 532 U.S. 483, 494–95 (2001).
72. See U.S. CONST. art. VI, cl. 2 (“This Constitution, and the Laws of the
United States which shall be made in pursuance thereof; and all treaties made,
or which shall be made, under the authority of the United States, shall be the
supreme law of the land; and the judges in every state shall be bound thereby,
anything in the constitution or laws of any state to the contrary
notwithstanding.”). The conflict occurs not because the states are obligated to
prohibit marijuana use. They are not required to adopt any particular criminal
law; what they must do it notify the public what they do make a crime. See Paul
J. Larkin, Jr., The Lost Due Process Doctrines, 66 CATH. U. L. REV. 293, 307–08
(2016). The conflict arises because the state legalization provisions allow an
activity prohibited by federal law.
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criminal liability.73
The Justice Department, however, has not aggressively
prosecuted individuals or businesses in states with
liberalized marijuana laws. In part, that approach reflects a
policy judgment regarding the proper allocation of law
enforcement resources—a decision that, as explained below,
Attorney General Jeff Sessions has revisited once and could
revisit again.74 In part, the Justice Department’s policy
reflects a limitation imposed by a series of congressional
appropriations riders that prohibit the department from
using federal funds to bring to a halt state medical marijuana
programs.75 The Fiscal Year 2018 appropriations bill carried

73. See, e.g., United States v. Rosenthal, 454 F.3d 943, 948 (9th Cir. 2006)
(ruling that the City of Oakland cannot “deputize” someone to distribute
marijuana under state law and render him immune from prosecution under
federal law); United States v. Stacy, 734 F. Supp. 2d 1074, 1080 (S.D. Cal. 2010)
(holding that state medical marijuana laws do not grant a person immunity from
prosecution under federal law); People v. Crouse, 388 P.3d 39 (Colo. 2017) (ruling
that the federal Controlled Substances Act preempts state constitutional
provisions requiring the return to an acquitted defendant of any marijuana seized
from him).
74. During the Clinton and Bush Administrations, the Justice Department
threatened physicians who prescribed marijuana with the loss of their federal
license to prescribe controlled substances and said that it aggressively prosecutes
marijuana distribution businesses. The Justice Department did not prosecute
individual patients, but it did pursue large-scale companies. During the Obama
Administration, the Justice Department publicly stated that it would not strictly
enforce federal law against patients and caregivers but would prosecute parties
and businesses that operated a marijuana dispensary as a sham for drug
trafficking or allied crimes, such as money laundering. See Larkin, Drugged
Driving, supra note 4, at 469–70, 470 n.75. In January 2018, Attorney General
Sessions repealed the Obama Administration’s Justice Department policies and
instructed the U.S. Attorneys to make changing decisions based on their own
assessment of the harms from marijuana trafficking in their respective districts.
See infra notes 97–99 and accompanying text.
75. See Consolidated and Further Continuing Appropriations Act of 2015,
Pub. L. No. 113-235, § 538, 128 Stat. 2130, 2217 (2014) (“None of the funds made
available in this Act to the Department of Justice may be used, with respect to
the States of Alabama, Alaska, Arizona, California, Colorado, Connecticut,
Delaware, District of Columbia, Florida, Hawaii, Illinois, Iowa, Kentucky, Maine,
Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri,
Montana, Nevada, New Hampshire, New Jersey, New Mexico, Oregon, Rhode
Island, South Carolina, Tennessee, Utah, Vermont, Washington, and Wisconsin,
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that provision forward, but it does not apply to recreational
marijuana programs or to other federal agencies.
There is an additional issue, however: can and should the
FDA address the distribution of edible cannabis on the
ground that THC-infused edibles are an “adulterated” food
and therefore cannot be distributed through interstate
commerce? The federal government ordinarily relies on the
Controlled Substances Act to address drug trafficking
because of the severity of its penalties, which, in some cases,
can result in life imprisonment.76 But that statute is not the
to prevent such States from implementing their own State laws that authorize
the use, distribution, possession, or cultivation of medical marijuana.”); Larkin,
Drugged Driving, supra note 4, at 464. Congress has carried forward that
provision in subsequent appropriations acts. See Continuing Appropriations Act,
2016, Pub. L. No. 114-53, § 104, 129 Stat. 502, 506 (2015); Further Continuing
Appropriations Act, 2016, Pub. L. No. 114-96, 129 Stat. 2193 (2015); Consolidated
Appropriations Act, 2016, Pub. L. No. 114-113, § 542, 129 Stat. 2242, 2332–33
(2015); Continuing Appropriations Act, 2017, Div. C of the Continuing
Appropriations and Military Construction, Veterans Affairs, and Related
Agencies Appropriations and Zika Response and Preparedness Act, Pub. L. No.
114-223, 130 Stat. 857, 908-20 (2016); Further Continuing and Security
Assistance Appropriations Act, 2017, Pub. L. No. 114-254, § 101, 130 Stat. 1005,
1006 (2016); H.R.J. Res. No. 99, Pub. L. No. 115-30, 131 Stat. 134 (2017);
Consolidated Appropriations Act, 2017, Pub. L. No. 115-31, 131 Stat. 135 (2017);
Continuing Appropriations Act, 2018 and Supplemental Appropriations for
Disaster Relief Requirements Act 2017, Div. D, Pub. L. No. 115-56, §§ 103–04,
131 Stat. 1129, 1139–47 (2018); H.R.J. Res. No. 123, Further Continuing
Appropriations Act, 2018, Div. A, Pub. L. No. 115-90, § 101, 131 Stat. 1280 (2017);
H.R. Res. 1370, 115th Cong. (2017) (enacted); Consolidated Appropriations Act,
2018, Pub L. No. 115-141, § 538 (Mar. 23, 2018). The appropriations rider was
originally named the Rohrabacher-Farr Amendment after the two
congressmen—Dana Rohrabacher and Sam Farr—who originally introduced it.
Now, it is known as the Rohrabacher-Blumenauer-Leahy Amendment. See Dana
Rohrabacher, My Fellow Conservatives Should Protect Medical Marijuana from
the Government, WASH. POST (Sept. 5, 2017), https://www.washingtonpost.com/
opinions/my-fellow-conservatives-should-protect-medical-marijuana-from-the-go
vernment/2017/09/05/73b60b0a-91aa-11e7-8754-d478688d23b4_story.html?utm
_term=.d31ac2ce3daa; Press Release, Congressman Dana Rohrabacher,
Rohrabacher Applauds Senate Panel for Adopting ‘Rohrabacher-Farr
Amendment’ (July 28, 2017), https://rohrabacher.house.gov/media-center/pressreleases/rohrabacher-applauds-senate-panel-for-adopting-rohrabacher-farr. For
convenience, I will refer to the amendment as the Rohrabacher Amendment.
76. See Paul J. Larkin, Jr., Crack Cocaine, Congressional Inaction, and Equal
Protection, 37 HARV. J. L. & PUB. POL’Y 241, 241–42 (2014) (discussing the penalty
structure of the Controlled Substances Act).
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only tool available to the government. The Federal Food,
Drug, and Cosmetic Act (FDCA) bans the introduction of
“adulterated” food into interstate commerce in order to
ensure the purity of the nation’s food supply.77 The question,
therefore, is whether the FDCA offers the government an
additional option it can use against the potential harms
posed by marijuana edibles.
It appears that the FDCA can be used in that manner.
The FDCA authorizes criminal prosecution, civil remedies,
and injunctive relief for a violation of its terms, including the
seizure of any adulterated foods.78 Under the FDCA, a “food”
77. 21 U.S.C. § 331(a)–(c) (2012) (“The following acts and the causing thereof
are prohibited: (a) The introduction or delivery for introduction into interstate
commerce of any food, drug, device, tobacco product, or cosmetic that is
adulterated or misbranded. (b) The adulteration or misbranding of any food,
drug, device, tobacco product, or cosmetic in interstate commerce. (c) The receipt
in interstate commerce of any food, drug, device, tobacco product, or cosmetic that
is adulterated or misbranded, and the delivery or proffered delivery thereof for
pay or otherwise.”). Misbranding of edibles can occur in (at least) two ways: They
can contain an inaccurate statement of their treatment value for different
medical conditions. See infra notes 128–37 and accompanying text. Or they can
mistakenly advertise the amount of THC in a product. See Vandrey et al., supra
note 18, at 2491 (“Edible cannabis products from 3 major metropolitan areas,
though unregulated, failed to meet basic label accuracy standards for
pharmaceuticals. Greater than 50% of products evaluated had significantly less
cannabinoid content than labeled, with some products containing negligible
amounts of THC. Such products may not produce the desired medical benefit.
Other products contained significantly more THC than labeled, placing patients
at risk of experiencing adverse effects. Because medical cannabis is recommended
for specific health conditions, regulation and quality assurance are needed.”)
(footnotes omitted).
78. 21 U.S.C. § 332 (2012) (authorizing injunctive relief); id. § 333
(authorizing criminal and civil penalties); id. § 334(a)(1) (authorizing judicial
seizure); id. § 334(g)–(h) (authorizing administrative detention of adulterated
and misbranded food and tobacco products); id. § 335b (authorizing civil
penalties); see generally 21 C.F.R. § 1.378 (2017) (authorizing administrative
detention of adulterated foods). The FDCA also authorizes the Commissioner of
Food, Drugs, and Cosmetics, as the designee of the Secretary of Health and
Human Services, 21 U.S.C. § 371(a); 21 C.F.R. § 5.10 (2017), to promulgate food
quality standards. 21 U.S.C. § 341 (“Whenever in the judgment of the Secretary
such action will promote honesty and fair dealing in the interest of consumers,
he shall promulgate regulations fixing and establishing for any food, under its
common or usual name so far as practicable, a reasonable definition and standard
of identity, a reasonable standard of quality, or reasonable standards of fill of
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is defined to include “articles used for food or drink for man”
and “articles used for components of any such article.”79 A
food is adulterated if it contains any added “poisonous or
deleterious substance which may render it injurious to
health”;80 marijuana edibles qualify. Aside from pesticides,
fungi, and other toxins,81 edibles contain THC, a potentially
container. . . . In prescribing a definition and standard of identity for any food or
class of food in which optional ingredients are permitted, the Secretary shall, for
the purpose of promoting honesty and fair dealing in the interest of consumers,
designate the optional ingredients which shall be named on the label.”).
79. 21 U.S.C. § 321(f) (2012).
80. Id. § 342(a)(1) (“A food shall be deemed to be adulterated . . . [i]f it bears
or contains any poisonous or deleterious substance which may render it injurious
to health . . . .”); id. § 346 (“Any poisonous or deleterious substance added to any
food, except where such substance is required in the production thereof or cannot
be avoided by good manufacturing practice shall be deemed to be unsafe for
purposes of the application of clause (2)(A) of section 342(a) of this title . . . .”); cf.
COLO. CODE REGS. § 212-2.103 (2017) (“‘Additive’ means any substance added to
Retail Marijuana Product that is not a common baking or cooking item.”).
81. The presence of harmful substances in marijuana products aggravates the
problem of edibles. Agricultural marijuana is not a standardized product. It can
vary by region, manner of cultivation, and potential contaminants. See, e.g.,
CAULKINS ET AL., MARIJUANA LEGALIZATION, supra note 5, at 34 (“One reason for
the lack of consensus is that marijuana is not a standardized good . . . .”); id. at
68 (“So asking about, or trying to study, the benefits (or harms) of marijuana
generically is a little bit like asking what wine tastes like, as if merlot and
champagne were interchangeable.”); see generally IVERSEN, supra note 12, at 5,
115–86. Various reports have also indicated that, despite efforts to avoid
contamination, marijuana sold in states such as Colorado and California have
been found to contain bacteria, mold, fungi, pesticides, heavy metals, and
solvents such as butane and propane. See, e.g., Franziska Busse et al., Lead
Poisoning Due to Adulterated Marijuana, 358 NEW ENGLAND J. MED. 1641 (2008);
Tista Ghosh et al., The Public Health Framework of Legalized Marijuana in
Colorado, 106 AM. J. PUB. HEALTH 21, 23 (2016) (“The medical literature reports
that marijuana can be contaminated by bacteria, mold, chemicals such as
pesticides, lead, ammonia, and formaldehyde.”) (footnotes omitted); Gourdet et
al., supra note 64, at 88; Subritzky et al., supra note 6, at 6 (“[T]he presence of
fungus and residues remains problematic in Colorado”); Contaminated Medical
Marijuana Believed to Have Killed Cancer Patient, CBS NEWS (Feb. 7, 2017, 11:08
AM), https://www.cbsnews.com/news/contaminated-medical-marijuana-pot-belie
ved-to-have-killed-cancer-patient/; Brian Handwerk, Modern Marijuana Is Often
Laced With Heavy Metals and Fungus, SMITHSONIAN (Mar. 23, 2015),
https://www.smithsonianmag.com/science-nature/modern-marijuana-more-pote
nt-often-laced-heavy-metals-and-fungus-180954696/ (“Concentrates and edibles
(think brownies) make up perhaps half of the current Colorado market . . . some
manufacturers employ potentially harmful compounds like butane to strip the
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harmful substance, as explained above. A “food additive” is
“any substance the intended use of which results or may
reasonably be expected to result, directly or indirectly, in its
becoming a component or otherwise affecting the
characteristics of any food” unless that substance is
generally recognized by experts “to be safe under the
conditions of its intended use.”82 THC certainly satisfies
plant of most everything but THC. Tests also show that marijuana plants can
draw in heavy metals from the soil in which they are grown, and concentrating
THC can increase the amounts of heavy metals, pesticides or other substances
that end up in a product. ‘People use all kinds of different methods to produce
concentrates,’ [Andy] LaFrate [founder of a laboratory certified to test cannabis]
says. ‘They allow people to use rubbing alcohol and heptane. But what grade of
solvents are they using? Are they buying heptane on eBay, and if so, what exactly
is in there? There are a whole bunch of issues to figure out, and right now there
are not enough resources and really no watchdog.’”); Brian Melley, Burners
Beware: California Pot Sold Jan. 1 Could be Tainted, ABC NEWS (Dec. 17, 2017),
http://abcnews.go.com/Technology/wireStory/burners-beware-california-pot-soldjan-tainted-51846148 (“Any marijuana sold when recreational sales become legal
Jan. 1 in the nation’s most populous state will have been grown without
regulatory controls that will eventually be in place. Pot could contain pesticides,
molds and other contaminants. ‘Buyer beware,’ cautioned Donald Land, a
University of California, Davis, chemistry professor who is the chief scientific
consultant at Steep Hill Labs Inc., which tests marijuana in several states.
Earlier this year, Land oversaw testing that found 93 percent of samples collected
by KNBC-TV from 15 dispensaries in four Southern California counties tested
positive for pesticides. That may come as a surprise for consumers who tend to
trust what’s on store shelves because of federal regulations by the U.S.
Agriculture Department or the U.S. Food and Drug Administration.
‘Unfortunately, that’s not true of cannabis,’ Land said. ‘They wrongly assume it’s
been tested for safety.’”); Lynne Peeples, Marijuana Pesticide Contamination
Becomes Health Concern as Legalization Spreads, HUFFINGTON POST (May 24,
2013;
7:44
AM),
https://www.huffingtonpost.com/2013/05/24/marijuanapesticides-contamination_n_3328122.html.
82. 21 U.S.C. § 321(s) (“The term ‘food additive’ means any substance the
intended use of which results or may reasonably be expected to result, directly or
indirectly, in its becoming a component or otherwise affecting the characteristics
of any food (including any substance intended for use in producing,
manufacturing, packing, processing, preparing, treating, packaging,
transporting, or holding food; and including any source of radiation intended for
any such use), if such substance is not generally recognized, among experts
qualified by scientific training and experience to evaluate its safety, as having
been adequately shown through scientific procedures (or, in the case of a
substance used in food prior to January 1, 1958, through either scientific
procedures or experience based on common use in food) to be safe under the
conditions of its intended use; except that such term does not include—(1) a
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those requirements. It is intended to become, and in fact
becomes, a component of an edible, and it has not been
proven to be safe. On the contrary, the FDA has concluded
that marijuana is not safe for use in any capacity. In fact,
Congress resolved that issue as a matter of law when it
placed marijuana in Schedule I of the Controlled Substances
Act, the category for drugs that, inter alia, pose a danger to
human health.83 That conclusion effectively ends the inquiry.
A state recreational marijuana law offers no shield against
enforcement of federal law, and the appropriations rider
noted above does not apply to recreational marijuana
programs or to the FDA. Accordingly, the FDCA empowers
the FDA to intervene against the sale of edibles.
However unusual it may seem, prohibiting edibles
alone—that is, without also prosecuting the sale of
marijuana to be smoked—is not an irrational choice, given
the marijuana regulatory regime we have today. Because
marijuana is contraband under federal law, the FDA and
Justice Department could seize any ingestible or inhalable
marijuana products that may be sold under state law, as well
as shut down the dispensary itself. To date, the FDA and the
Justice Department have not pursued that strategy,
preferring to focus on sham distribution schemes and sales
to minors. If the government decides to continue with that
approach, it could readily pursue administrative, civil, and
criminal actions against the sale of edibles, given the
certainty that, as a practical matter, edibles will wind up in
the hands of minors. The result would be that the
government could shut down the distribution of THC-infused
foods, while allowing marijuana to be sold in non-edible
pesticide chemical residue in or on a raw agricultural commodity or processed
food; or (2) a pesticide chemical; or (3) a color additive; or (4) any substance used
in accordance with a sanction or approval granted prior to September 6, 1958,
pursuant to this chapter, the Poultry Products Inspection Act [21 U.S.C.A. § 451
et seq.] or the Meat Inspection Act of March 4, 1907, as amended and extended
[21 U.S.C.A. § 601 et seq.]; (5) a new animal drug; or (6) an ingredient described
in paragraph (ff) in, or intended for use in, a dietary supplement.”).
83. Larkin, Drugged Driving, supra note 4, at 460 & n.27.
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forms, as a way to lessen the risk that minors, particularly
children, will consume attractive, innocent-looking brownies,
candies, and the like.84
To be sure, this two-pronged approach is an odd way to
approach this problem. Stopping the commercial production
of edibles would drive some people to make their own—where
there is no quality control—and some others to smoke
marijuana—which creates its own set of problems. As long
as the concentrated form of marijuana is available, some
people will make their own edibles. (That is particularly true
if, as seems likely, the price of concentrate will fall, due to a
decreased demand, if edibles are banned.) The result will be
a lack of statewide quality control, which increases the risk
of an unintentional overdose, particularly by minors who are
amateur chefs—and amateur chemists—as well as a greater
risk of consuming a product contaminated with various
toxins. If people switch to smoking marijuana, there are
other risks. No other drug is smoked because smoking does
not guarantee that a predetermined amount of a medicine
will be delivered to the body—for example, there is no
uniform number of “puffs” or depth of an individual puff—
and smoking marijuana carries with it many of the harms of
smoking tobacco—for example, it irritates the lung tissues.
Nonetheless, like all compromise solutions, this one is not
perfect, but it does address one fear that society has.
Why then has the FDA not taken any step to halt the
distribution of edibles since California enacted the first
medical marijuana law in 1996? Three explanations come to
mind.
One is that the FDA decided to leave the entire subject
of marijuana to the federal law enforcement agencies
because the Controlled Substances Act deems marijuana
contraband.85 That is, the FDA saw no reason to regulate the
84. A narrower option would be to stop the interstate distribution of sweetened
edibles, given that a high sugar content may attract children.
85. The Controlled Substances Act was enacted as Title II of the
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sale of a drug that cannot be lawfully sold.86 That
explanation makes sense on its face, but is ultimately flawed
in the case of edibles. A rule prohibiting a particular
substance from being added to food is a form of regulation,
but it does not imply that all other substances are
permissible additives. In other words, the directive, “you may
not add A to food,” does not imply that B, C, and the other
letters in the alphabet can be included in a food product sold
to the public. To eliminate any doubt, the FDA could make
that point in the same rule banning the sale of edibles.87
The second reason may be that the agency chose to avoid
becoming involved in the battles over the proper federal
Comprehensive Drug Abuse Prevention and Control Act of 1970, Pub. L. No. 91513, 84 Stat. 1236. Under that act, a “controlled substance” is “a drug or other
substance, or immediate precursor, included in schedule I, II, III, IV, or V of part
B of this title,” except for “distilled spirits, wine, malt beverages, or tobacco, as
those terms are defined or used in subtitle E of the Internal Revenue Code of
1954.” 21 U.S.C. § 802(6) (2012). The Controlled Substances Act incorporates the
definition of a “drug” from the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.
§ 201 (g)(1) (2017). Congress placed marijuana in Schedule I when it enacted the
Controlled Substances Act. See Alliance for Cannabis Therapeutics v. DEA, 930
F.2d 936, 937 n.1 (D.C. Cir. 1991). Marijuana (and its salts, isomers, and
synthetic equivalents) remains on that list today. 21 C.F.R. § 1308.11(d)(31)
(2017). Drugs placed on Schedule I drugs are one found to have no accepted
medical use and pose a serious danger of harm and addiction. Physicians cannot
prescribe Schedule I drugs. Larkin, Drugged Driving, supra note 4, at 460 &
nn.26–27.
86. MacCoun & Mello, supra note 8, at 990.
87. The FDA could say something like this:
Section 1: Because THC and other ingredients in marijuana can have
adverse effects on people, food products, commonly known as ‘edibles,’
cannot be distributed in interstate commerce if they contain THC or
other cannabinoids found in marijuana. Section 2: The ban in Section 1
on the use of THC or other cannabinoids in food is not a license or
approval to distribute those substances in interstate commerce in any
other manner.
An agency generally has the last word on the meaning of its own regulations
unless its reading is inconsistent with the text of the rule. Under settled law,
when an agency’s interpretation of its own regulation is at stake, “the ultimate
criterion is the administrative interpretation, which becomes of controlling
weight unless it is plainly erroneous or inconsistent with the regulation.” See
Bowles v. Seminole Rock & Sand Co., 325 U.S. 410, 414 (1945); accord, e.g., Auer
v. Robbins, 519 U.S. 452, 461 (1997) (reaffirming the Seminole Rock standard).
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response to state marijuana legalization. Current
legalization proposals focus on the recreational use of
marijuana, but the initial proposals sought only to permit
marijuana to be used as a “treatment” for various afflictions.
Supporters of medical marijuana argued that it could help
alleviate the suffering of the dying or grievously impaired,
particularly when smoked.88 They pointed to individuals
disabled by chemotherapy-induced nausea and vomiting, the
weight loss associated with HIV/AIDS, the neuropathic pain
and spasticity afflicting victims of multiple sclerosis, the
chronic pain in adults that over-the-counter analgesics
cannot assuage, and the sleep disturbances that are
consequent upon several different diseases.89 Supporters
also argued that it is irrational to be worried about long-term
health problems for someone who is in the end stages of a
terminal disease or is presently suffering from the type of
intractable pain, nausea, and vomiting that would make
anyone wish that death were near.90 The FDA may have
decided that Presidents Clinton, Bush, and Obama were
unwilling to endure the political blowback that would result
from armed federal agents seizing marijuana from hospices
and homes that would be displayed all-day across television
screens. The FDA may have feared that intervening in this
fray would lead to irreparable damage to its authority and
image from being chastened by the media and corralled by
the president, and perhaps, Congress. The FDA may have
88. Smoked plant-form marijuana, supporters contend, is superior to other,
synthetic THC delivery vehicles (e.g., pills, inhalants, and suppositories)
approved by the U.S. Food and Drug Administration (e.g., Dronabinol) or other
nations (e.g., Nabiximol) because inhalation works more effectively and more
quickly, reaching the brain within seconds. See, e.g., NAT’L ACAD. REP., supra note
5, at 54; IVERSEN, supra note 12, at 45–47.
89. See, e.g., NAT’L ACAD. REP., supra note 5, at 128 (listing conditions for
which marijuana is a treatment for which there are varying degrees of scientific
support); IVERSEN, supra note 12, at 131, 140–48, 162; Volkow et al., supra note
28, at 2224 (listing clinical conditions with symptoms marijuana may alleviate);
supra note 28.
90. See, e.g., Jerome P. Kassirer, Federal Foolishness and Marijuana, 336
NEW ENG. J. MED. 366, 366 (1997).
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decided to wait until it was sure that the political branches
would support its intervention.
That wait may not yet be over. The federal political
branches have yet to decide on the appropriate federal
response to state marijuana legalization. Congress has
largely stayed out of the debate. With the one exception
adumbrated above and discussed below regarding the
Justice Department’s prosecution policies, Congress has
studiously avoided any serious debate over the legality of
medical or recreational marijuana. As far as the executive
branch goes, the administrations of former Presidents Bill
Clinton, George W. Bush, and Barack Obama did not come
to a settled position. From 1996, when California adopted the
first medical marijuana initiative, through the end of the
Obama Administration, the Justice Department has gone
back and forth on the issue of whether it should prosecute
the sale of marijuana in states with medical and recreational
marijuana régimes. In fact, the initial response, set forth
early in 1997, only three months after California passed its
medical marijuana initiative, by Barry McCaffrey, the highprofile Director of the Office of National Drug Control Policy
in the Clinton Administration, was to threaten any physician
who prescribed marijuana for a patient with the loss of his
license to prescribe controlled substances.91 The Clinton and
Bush Administrations also signaled that they would ignore
the state liberalization measures and prosecute businesses
distributing cannabis.92 By contrast, the Obama
Administration adopted a policy of largely declining to
enforce federal law against patients, caregivers, and
recreational users and of focusing on businesses engaged in

91. McCaffrey made that point in no uncertain terms. See Administration
Response to Arizona Proposition 200 and California Proposition 215, 62 Fed. Reg.
6164, 6164 (Feb. 11, 1997) (warning that the “DEA will seek to revoke the DEA
registrations of physicians who recommend or prescribe Schedule I controlled
substances”).
92. Larkin, Drugged Driving, supra note 4, at 469.
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large-scale trafficking in cannabis or the sale to minors.93
Indeed, the growth in states’ medical marijuana programs
coincides with the release in October 2009 of a memorandum
signed by Deputy Attorney General David Ogden—known as
the Ogden Memorandum—announcing a policy that was
seen as a hands-off approach toward the sale of medical
marijuana in compliance with state law, while the growth in
recreational marijuana laws resulted from the 2013 Cole
Memorandum, which signaled that the Justice Department
would take the same approach toward state recreational
marijuana programs as long as they were applied in
accordance with state law.94 The Justice Department
represented the FDA in federal court,95 so it may have made
little sense to the agency to adopt a position treating edibles
as adulterated under the FDCA if the Justice Department
would not defend that position in court.
It is unclear what will happen now. In 2017, Attorney

93. See Memorandum from James M. Cole, Deputy Att’y Gen., U.S. Dep’t of
Justice, for United States Attorneys on Guidance Regarding Marijuana
Enforcement (Aug. 29, 2013); Memorandum from David W. Ogden, Deputy Att’y
Gen., U.S. Dep’t of Justice, for Selected United States Attorneys on Investigations
and Prosecutions in States Authorizing the Medical Use of Marijuana (Oct. 19,
2009); see also Memorandum from James M. Cole, Deputy Att’y Gen., U.S. Dep’t
of Justice, for United States Attorneys on Guidance Regarding Marijuana
Related Financial Crimes (Feb. 14, 2014); Memorandum from James M. Cole,
Deputy Att’y Gen., U.S. Dep’t of Justice, for United States Attorneys on Guidance
Regarding the Ogden Memo in Jurisdictions Seeking to Authorize Marijuana for
Medical Use (June 30, 2011); BARCOTT, supra note 55, at 65.
94. See Monte et al., supra note 5, at 241 (“Few patients used medical
marijuana until October 2009, when the US Attorney General distributed
guidelines for federal prosecution of the possession and use of marijuana, ceding
jurisdiction of marijuana law enforcement to state governments. The combination
of permissive local law and the federal policy change effectively liberalized the
sale and use of medical marijuana in Colorado. Anyone with one of the conditions
outlined by Colorado law could be issued a medical marijuana license with no
expiration date. The number of licenses increased from 4819 on December 30,
2008, to 116 287 on September 30, 2014.”); Onders, supra note 30, at 433; Wang
et al., Multistate Study 2005–2011, supra note 14, at 688.
95. See 28 U.S.C. §§ 503, 506, 509–519 (2006) (authorizing the Attorney
General to supervise all federal litigation); FDA ENFORCEMENT MANUAL ¶ 1220
(2015).
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General Jeff Sessions said that the widespread sale of
marijuana was harmful for the nation, which indicated a
willingness to reconsider the enforcement positions of his
predecessors.96 On January 4, 2018, he decided to revisit the
Justice Department’s policy and both the Cole and Ogden
Memoranda.97 The Sessions Memorandum stated that U.S.
Attorneys should make charging decisions based on the
seriousness of marijuana trafficking in their respective
jurisdictions.98
The 2018 Sessions Memorandum does not indicate that
it will be the only change in marijuana policy that we may
see in the Trump Administration. Sessions may not attempt
to fully return the department to the position that it held
prior to the post-1996 state marijuana reform efforts, but
there is additional room for him to expand the department’s
efforts to suppress large-scale commercial marijuana
operations. If he does, he may decide to enlist the FDA’s
support, and, if he does, that would prevent the FDA from
standing on the sidelines. A formal declaration by Attorney
General Sessions that the executive branch will aggressively
pursue civil and criminal enforcement actions against the
distribution of marijuana edibles under the Controlled
Substances Act and FDCA would force the FDA to take a
position on one side or the other regarding its enforcement
authority and priorities. That might lead President Trump
and Congress to enter the fray as well.
Regardless of what executive branch officials decide to
do, marijuana legalization’s supporters will pressure
96. See, e.g., Tom Angell, Jeff Sessions Slams Marijuana Legalization (Again),
FORBES (Sept. 27, 2017), https://www.forbes.com/sites/tomangell/2017/09/20/jeffsessions-slams-marijuana-legalization-again/#3afea92a27d1.
97. Press Release, U.S. Dep’t of Justice, Marijuana Enforcement (Aug. 29,
2013) (on file with author), https://www.justice.gov/opa/press-release/file/
1022196/download; see Charlie Savage & Jack Healy, Trump Administration
Takes Step That Could Threaten Marijuana Legalization Movement, N.Y. TIMES
(Jan. 4, 2018), https://www.nytimes.com/2018/01/04/us/politics/marijuanalegalization-justice-department-prosecutions.html.
98. See Press Release, U.S. Dep’t of Justice, supra note 97.
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Congress to halt any aggressive use of federal law to stem
the sale of edibles. Marijuana legalization is potentially a
huge business for private parties and a new source of
revenue for states. Estimates are that marijuana legalization
will generate thousands of jobs, along with billions of dollars
in revenues for private parties and state governments over
the next few years.99 People who stand to make or lose that
99. See, e.g., Debra Borchardt, Marijuana Industry Projected to Create More
Jobs
than Manufacturing by
2020,
FORBES (Feb.
22,
2017),
https://www.forbes.com/sites/debraborchardt/2017/02/22/marijuana-industryprojected-to-create-more-jobs-than-manufacturing-by-2020/ (“A new report from
New Frontier Data projects that by 2020 the legal cannabis market will create
more than a quarter of a million jobs. This is more than the expected jobs from
manufacturing, utilities or even government jobs, according to the Bureau of
Labor Statistics. The BLS says that by 2024 manufacturing jobs are expected to
decline by 814,000, utilities will lose 47,000 jobs and government jobs will decline
by 383,000. This dovetails with data that suggests the fastest-growing industries
are all healthcare related. The legal cannabis market was worth an estimated
$7.2 billion in 2016 and is projected to grow at a compound annual rate of 17%.
Medical marijuana sales are projected to grow from $4.7 billion in 2016 to $13.3
billion in 2020. Adult recreational sales are estimated to jump from $2.6 billion
in 2016 to $11.2 billion by 2020.”); Rory Campbell, Hippy Dream Now a BillionDollar Industry with California Set to Legalize Cannabis, GUARDIAN (Dec. 30,
2017), https://amp.theguardian.com/us-news/2017/dec/30/california-legalise-can
nabis-hippy-dream-billion-dollar-industry (“The Salinas Valley, an agricultural
zone south of San Francisco nicknamed America’s salad bowl, has already earned
a new moniker: America’s cannabis bucket. Silicon Valley investors and other
moneyed folk are hoping to mint fortunes by developing technology to cultivate,
transport, store and sell weed. Entrepreneurs are devising pot-related products
and services. Financiers are exploring ways to fold the revenue – estimated at
$7bn per annum by 2020—into corporate banking.”); Chris Morris, Legal
Marijuana Sales Are Expected to Hit $10 Billion This Year, FORTUNE (Dec. 6,
2017), http://fortune.com/2017/12/06/legal-marijuana-sales-10-billion/; Aaron
Smith, Market for Legal Pot Could Pass $20 Billion, CNN MONEY (Nov. 11, 2017,
7:08 AM), http://money.cnn.com/2016/11/09/news/economy/marijuana-legalizat
ion-sales/index.html (“Voters in four states approved legal recreational pot on
Tuesday. Four more states expanded access to medical marijuana. All told, it
could expand the national market to $21 billion by 2020, according to New
Frontier Data, which partnered with the marijuana industry organization
Arcview Group. That is up from $5.7 billion last year and an expected $7.9 billion
this year.”); Aaron Smith, Colorado Passes a Milestone for Pot Revenue, CNN
MONEY (July 19, 2017, 2:52 PM), http://money.cnn.com/2017/07/19/news/
colorado-marijuana-tax-revenue/index.html (“VS Strategies, a pro-legalization
research company in Denver, says that the state has pulled in $506 million since
retail revenues began in January 2014. . . . Revenue from taxes and fees has
increased each year, from $76 million in 2014 to $200 million last year, and the
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much money are not likely to watch idly as elected federal
officials decide what to do. If they are not already making
their voices heard in Congress—especially to members of the
California delegation—they will.100
The third reason why the FDA may have chosen to stand
on the sidelines is that the federal government may have
broadly read an appropriations rider restricting the Justice
Department from nullifying state medical marijuana
programs. As explained above, in 2014, Congress added a
provision to the Consolidated and Further Continuing
Appropriations Act of 2015, prohibiting the Department of
Justice from using federal funds to “prevent such States from
implementing their own State laws that authorize the use,
distribution, possession, or cultivation of medical
marijuana.”101 The U.S. Court of Appeals for the Ninth
Circuit construed that provision in 2016 in a case involving
large-scale traffickers, United States v. McIntosh.102 The
state is on track to beat that this year, according to VS Strategies, which used
state revenue data in its report Wednesday.”).
100. See Morris, supra note 99 (“California’s medical marijuana market is
already as big as the total markets in Colorado, Washington, and Oregon
combined, according to BDS Analytics’ GreenEdge point-of-sale tracking service.
Given the boost from that state and others that could change their laws (including
New Jersey), Arcview says that it expects the legal cannabis market to reach
sales of $24.5 billion by 2021.”).
101. See Consolidated and Further Continuing Appropriations Act of 2015,
supra note 75.
102. 833 F.3d 1163 (9th Cir. 2016). The facts were the following:
In McIntosh, five codefendants allegedly ran four marijuana stores in
the Los Angeles area known as Hollywood Compassionate Care (HCC)
and Happy Days, and nine indoor marijuana grow sites in the San
Francisco and Los Angeles areas. These codefendants were indicted for
conspiracy to manufacture, to possess with intent to distribute, and to
distribute more than 1000 marijuana plants in violation of 21 U.S.C. §§
846, 841(a)(1), 841(b)(l)(A). The government sought forfeiture derived
from such violations under 21 U.S.C. § 853. In Lovan, the U.S. Drug
Enforcement Agency and Fresno County Sheriff’s Office executed a
federal search warrant on 60 acres of land located on North Zedicker
Road in Sanger, California. Officials allegedly located more than 30,000
marijuana plants on this property. Four codefendants were indicted for
manufacturing 1000 or more marijuana plants and for conspiracy to
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defendants argued that the rider barred the government
from prosecuting them for any marijuana-related offense
because they were licensed under California and Washington
state law to grow and distribute marijuana. McIntosh held
that the appropriations rider bars the federal government
from prosecuting someone who fully complies with the
medical marijuana laws in his state. The court reasoned
that, “[i]f the federal government prosecutes such
individuals, it has prevented the state from giving practical
effect to its law providing for non-prosecution of individuals
who engage in the permitted conduct.”103 During the Obama
Administration, the Justice Department might have
concluded that the McIntosh case was correctly decided. If so,
the department read that case too broadly.
The Ninth Circuit concluded that the California and
Washington laws sought to immunize parties from a federal
prosecution if they complied with state law. The relevant
issue in McIntosh, however, was whether the criminal
prosecution brought in McIntosh would “prevent” those
states from “implementing” their medical marijuana
program. It is difficult to see how any one prosecution would
“prevent” a state from “implementing” such a program as
long as other uncharged parties can grow and distribute

manufacture 1000 or more marijuana plants in violation of 21 U.S.C. §§
841(a)(1), 846. In Kynaston, five codefendants face charges that arose
out of the execution of a Washington State search warrant related to an
investigation into violations of Washington’s Controlled Substances Act.
Allegedly, a total of 562 ‘growing marijuana plants,’ along with another
677 pots, some of which appeared to have the root structures of
suspected harvested marijuana plants, were found. The codefendants
were indicted for conspiring to manufacture 1000 or more marijuana
plants, manufacturing 1000 or more marijuana plants, possessing with
intent to distribute 100 or more marijuana plants, possessing a firearm
in furtherance of a Title 21 offense, maintaining a drug-involved
premise, and being felons in possession of a firearm in violation of 18
U.S.C. §§ 922(g)(1), 924(c)(1)(A)(i) and 21 U.S.C. §§ 841, 856(a)(1).
Id. at 1169.
103. Id. at 1177.
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marijuana.104 In any event, the purpose of the rider is to keep
the Justice Department from bringing a criminal prosecution
against someone involved in the distribution of medical
marijuana, not recreational marijuana. The omission of the
latter is significant because Congress certainly knows about
the difference and, by declining to keep the Justice
Department from charging people or businesses involved in
recreational marijuana sales, did not intend to prevent the
Justice Department from prosecuting the latter.
Legalization’s supporters will argue that, although the
Rohrabacher Amendment does not specifically refer to the
FDA, the Justice Department is the FDA’s lawyer, and the
amendment limits the department’s ability to represent its
client. That is, the argument will be that the amendment
should not be limited to keeping the Justice Department
from bringing criminal prosecutions or asset-forfeiture
proceedings, but should also be read to bar the department’s

104. There is an additional factor to consider—namely, the appropriations
rider cannot be read broadly. A government official who violates an
appropriations law limitation can be criminally prosecuted for his actions under
the Antideficiency Act. See 31 U.S.C. § 1341(a)(1)(A) (2012) (“An officer or
employee of the United States Government or of the District of Columbia
government may not . . . make or authorize an expenditure or obligation
exceeding an amount available in an appropriation or fund for the expenditure
or obligation . . . .”); 31 U.S.C. § 1350 (“An officer or employee of the United States
Government or of the District of Columbia government knowingly and willfully
violating section 1341(a) or 1342 of this title shall be fined not more than $5,000,
imprisoned for not more than 2 years, or both.”). The appropriations rider has the
effect of a criminal law, which means it cannot be read broadly and any doubt as
to its meaning must be resolved by application of the Rule of Lenity. See, e.g.,
United States v. Santos, 553 U.S. 507, 514 (2008) (plurality opinion); Paul J.
Larkin, Jr., Chevron and Federal Criminal Law, 33 J. L. & POL. 211, 228–29
(2017). That is significant because the term “prevent” can be read narrowly, as
meaning to “avert” or “keep [something] from occurring,” or broadly, as including
an action that “hinders” someone from acting. See Dictionary.com (“prevent”:
“verb (used with object) 1. to keep from occurring; avert; hinder: He intervened
to prevent bloodshed. 2. to hinder or stop from doing something: There is nothing
to prevent us from going. 3. Archaic. to act ahead of; forestall. 4. Archaic. to
precede.
5.
Archaic.
to
anticipate.”).
Prevent,
DICTIONARY.COM,
http://www.dictionary.com/browse/prevent?s=t (last visited Feb. 17, 2018).
Because the Antideficiency Act is a criminal statute, the term “prevent” should
be narrowly read to mean “halt,” not broadly to include “hinder.”
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lawyers from representing the FDA in any action that would
have the effect of shutting down a state’s medical marijuana
regime. The purpose of the Rohrabacher Amendment is to
allow states to decide whether to operate medical marijuana
programs without fear that the Justice Department will use
its litigating authority to shut down any such operation.
Accordingly, the amendment should be construed broadly so
that it prohibits Justice Department lawyers from
representing the FDA if it were to bring an enforcement
action against a business on the ground that it sold
marijuana edibles that were adulterated or misbranded.
That argument
unpersuasive.

is

inventive,

but

ultimately

is

Start with the fact that the Rohrabacher Amendment
does not repeal or revise the FDCA, nor does it limit what
the FDA can do with its appropriated funds. The amendment
therefore does not affect the ability of the FDA to pursue
whatever steps it can independently take to prevent the
distribution of adulterated foods in interstate commerce.
Given that Congress has not forbidden the FDA from taking
action under the FDCA against adulterated or misbranded
food products, it is unreasonable to construe the
Rohrabacher Amendment as limiting the FDA’s authority to
protect the public health. After all, it is the FDA’s mission to
prevent adulterated or misbranded food products from
entering the stream of commerce. The Justice Department is
merely the agency’s lawyer.
That distinction is an important one. It was not the fear
of actions potentially undertaken by the FDA to prevent the
distribution of adulterated or misbranded food or drugs that
lead Representative Dana Rohrabacher to propose, and
Congress to adopt the Rohrabacher Amendment; nor was it
the Justice Department’s role as the FDA’s in-court counsel
that saw to the amendment’s passage. It was the fear of
armed federal agents arresting seriously ill medical patients
and removing them from their homes, nursing facilities, or
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hospices.105 In some instances, that was more than a mere
“fear.” In 2002, Drug Enforcement Administration agents
entered the home of a medical marijuana patient and seized
six marijuana plants. As one commentator put it:
105. See Rohrabacher, supra note 75 (“I wrote an amendment to spending bills
that prohibits the federal government from prosecuting medical marijuana cases
in states where voters have legalized such treatment.”); Alex Kreit, Beyond the
Prohibition Debate: Thoughts on Federal Drug Laws in an Age of State Reforms,
13 CHAPMAN L. REV. 555, 569–70 (2010) (“Between them, [Gonzales v. Raich, 545
U.S. 1 (2005) and United States v. Oakland Cannabis Buyers’ Coop., 532 U.S.
483, 494–95 (2001)] left little doubt that federal officials could constitutionally
prosecute medical marijuana growers, providers, and even patients themselves.
And, throughout the past decade, the federal government enthusiastically
exercised this authority, at least in California. It has raided at least 190 medical
marijuana collectives and brought criminal charges against medical marijuana
growers and collective operators, many of whom were operating in strict
compliance with California’s law. In one high profile prosecution, for example,
the federal government obtained a conviction against Charlie Lynch, who
operated a medical marijuana collective in Morro Bay, California. Lynch had the
backing of town officials and even held a ribbon-cutting ceremony attended by
the mayor and members of the city council when he opened up shop. At his
sentencing, District Court Judge George H. Wu indicated some displeasure with
having to impose a one-year jail sentence for Lynch. The New York Times
reported that Wu ‘talked at length about what he said were Mr. Lynch’s many
efforts to follow California’s laws on marijuana dispensaries’ before concluding: ‘I
find I cannot get around the one-year sentence . . . .’ The DEA has even gone after
landlords who have knowingly rented their property to medical marijuana
collective operators and growers through asset forfeiture proceedings.”)
(footnotes omitted); Zach Harris, A Brief History of Rohrabacher-Farr: The
Federal Amendment Protecting Medical Marijuana, MERRY JANE (Dec. 19, 2017),
https://merryjane.com/news/a-brief-history-of-rohrabacher-farr-the-federalamendment-protecting-medical-marijuana
(“[T]he
Rohrabacher-Farr
amendment . . . prevents the Department of Justice from spending federal funds
to prosecute cannabis-related activities if they are permitted under state-specific
medical marijuana laws.”); Michael M. O’Hear, Federalism and Drug Control, 57
VAND. L. REV. 783, 840 n.322 (2004) (“Federal agents have raided medical
marijuana distribution organizations in West Hollywood, San Francisco,
Oakland, and Sebastopol.”); Maria Alicia Gaura, Santa Cruz Officials Fume over
Medical Pot Club Bust/DEA Arrests Founders, Confiscates Plants, S.F. CHRON.
(Sept. 6, 2002), http://www.sfgate.com/bayarea/article/Santa-Cruz-officials-fumeover-medical-pot-club-2773777.php; Charlie LeDuff & Adam Liptak, Defiant
California City Hands Out Marijuana, N.Y. TIMES (Sept. 18, 2002),
http://www.nytimes.com/2002/09/18/us/defiant-california-city-hands-out-mariju
ana.html; cf. Gonzales v. Raich, 545 U.S. 1 (2005) (lawsuit brought against the
attorney general and the DEA to enjoin the enforcement of the federal controlled
substances laws against the use of home-grown marijuana for medical purposes);
supra notes 7, 69 & 71.
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When thirty federal Drug Enforcement Administration (DEA)
agents armed with M-16s burst into a medical marijuana hospice in
Santa Cruz, California, on September 5, 2002, arresting the two
owners and a wheelchair-bound patient disabled by polio, they
propelled an already contentious debate between the federal
government and state leaders to new heights.106

Those events in a California town could not have been lost on
Dana Rohrabacher, a Congressman from California, when he
offered his amendment. That fear still resonates today.107
106. Alex Kreit, Comment, The Future of Medical Marijuana: Should the
States Grow Their Own?, 151 U. PA. L. REV. 1787, 1787 (2003) (footnotes omitted);
see also, e.g., HUDAK, supra note 15, at 141 (“[T]he Clinton and George W. Bush
administrations tried to enforce federal law, authorizing the DEA and the FBI to
work with local law enforcement to raid medical marijuana operations across the
American West. Grow operations and processors were shut down. Co-op
participants were handcuffed and assets were seized. Anecdotes abound of
terminally ill patients being treated like street criminals for being caught tending
their plants when federal agents arrived”). That incident sparked considerable
political protest in California. Kreit, supra, at 1787–88 (“In response, Santa Cruz
officials, who had ‘cooperated closely’ with the hospice for six years, ’issued a
provocative public challenge’” to the DEA by organizing an event to distribute
medical marijuana on the steps of City Hall. Mayor Christopher Krohn, who
attended the event alongside city council members, said that ‘[c]learly, state law
and federal law are on a collision course’ and vowed to stand by the hospice until
federal law changed. Vice-Mayor Emily Reilly went even further, calling it
‘absolutely loathsome . . . that federal money, energy and staff time would be
used to harass people like this. . . . The outrage spread quickly from Santa Cruz
to other parts of California. Patients organized protests across the state, and
‘State Attorney General Bill Lockyer protested and demanded a meeting with
[U.S. Attorney General John] Ashcroft.’ Just a few weeks after the Santa Cruz
City Hall event, San José Police Chief William Lansdowne removed his officers
from the DEA’s High Intensity Drug Trafficking Area task force in protest.
Officials in other California cities followed San José’s lead and asked their police
officers to ‘stop cooperating with federal agents.’”) (footnotes omitted);
Christopher Krohn, Opinion, Why I’m Fighting Federal Drug Laws from City
Hall, N.Y. TIMES, Sept. 21, 2002, at A15 (“How did I, a mayor of a small town in
California, wind up in a tug of war with the Drug Enforcement Agency? This
week, I stood in front of Santa Cruz’s city hall as a local group that provides
medical marijuana went about its weekly task of distributing the drug to the sick
and dying. . . . My story begins on the morning of Sept. 5 when approximately 30
men, dressed in military fatigues and carrying automatic weapons, descended on
a small cooperative farm run by the Wo/Men’s Alliance for Medical Marijuana in
northern Santa Cruz County, about 65 miles south of San Francisco.”).
107. See, e.g., Robin Abcarian, Drug War Overkill: A Post Bust against Legal
Growers in Yolo County Seems to Go Too Far, L.A. TIMES (Jan. 6, 2017),
http://www.latimes.com/local/abcarian/la-me-abcarian-pot-bust-20170106-
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It is important to remember that protecting the public
against adulterated food is one of the FDA’s historic
missions. This task originated in the Pure Food and Drug Act
of 1906.108 Signed into law by President Theodore Roosevelt
on the same day that he signed the companion bill, Federal
Meat Inspection Act of 1906,109 the Pure Food and Drug Act
was a response to “extensive evidence of product adulteration
and industrial fraud,” as described in Upton Sinclair’s novel
story.html (“I sat with Hicks and Mears on Wednesday in the office of their
Sacramento attorney, Mark Reichel, and both grew tearful as they recalled the
terror they felt when dozens of gun-wielding officers pounded on their front doors
the morning of Sept. 14. ‘I told my 2-year-old son to stay upstairs,’ said Mears,
35. ‘When I opened the security door, there were 15 cops with assault rifles
drawn, pointed, with their fingers on the trigger, in vests, ski masks. They
grabbed me and pulled me out front, put me in handcuffs. There were 20 to 30
officers. My son walked downstairs and my wife had to grab him. They had guns
pulled on them. It was real painful. Easily, it was the worst day of my life,’ said
Hicks, 43. ‘Every gun you can imagine was pointed at me. I was like, ‘Why is this
happening?’ To add icing to the cake, it was my son’s fourth birthday.’”); Thomas
Fuller, Medical Marijuana Is Legal in California. Except When It’s Not, N.Y.
TIMES (Nov. 21, 2016), https://www.nytimes.com/2016/11/22/us/medical-mariju
ana-is-legal-in-california-except-when-its-not.html
(“CannaCraft
produces
medical marijuana products, which have been legal in the state for two decades,
but operated in a kind of Wild West, unregulated market. In June, the company’s
newly opened headquarters was raided by federal and local law enforcement
officers, who said the process it used to make marijuana products was dangerous
and illegal. . . . In May, the company hosted nearly 50 state lawmakers and
regulators from Sacramento, the state capital, to demonstrate the process it uses
to produce the soft-gel capsules and other cannabis-based products that do not
involve smoking. . . . But two weeks after the visit . . . around 100 officers and
agents wearing tactical gear, and representing multiple law enforcement
agencies, raided the company’s headquarters and four other facilities.”);
Angelique Moss, Collision of Federal and State Laws about Medical Marijuana
Threatens to Make Patients, Legal ‘Casualties,’ POLICY (May 15, 2016),
https://thepolicy.us/collision-of-federal-and-state-laws-about-medical-marijuanathreatens-to-make-patients-legal-483a0865e738 (“The growth, manufacture, and
distribution of medical marijuana have all been legalized in 24 U.S. states, but
current federal laws which prohibit their use are placing well-meaning medical
marijuana patients and doctors in legal jeopardy. As the Department of Justice,
politicians, and lawyers on both sides wrestle with the reconciliation and
resolution of the application of two contradicting laws in one location, the friendly
neighbor down the street who grows his own cannabis in order to treat his child’s
epileptic illness can face arrest, prosecution, and possible imprisonment.”).
108. Act of June 30, 1906, ch. 3915, Pub. L. No. 59-348, 34 Stat. 786 (1906).
109. Act of March 4, 1907, ch. 2907, Pub. L. No. 59-242, 34 Stat. 1256 (1906).
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The Jungle and other then-contemporary publications.110
With respect to food, the act provided that “an article shall
be deemed to be adulterated” if it contained “any added
poisonous or other added deleterious ingredient which may
render such article injurious to health,”111 while a food would
be deemed “misbranded” if it were “labeled or branded so as
to deceive or mislead the purchaser.”112 To enforce that
section, the act assigned to the U.S. Department of
Agriculture’s Bureau of Chemistry, which ultimately became
the FDA, the responsibility to prevent the shipment of
adulterated or misbranded foods in interstate commerce by
inspecting food and drug products and referring violators for
prosecution.113 The Pure Food and Drug Act “prohibited the
addition of any ingredients that . . . [would] pose a health
hazard.”114 When the FDA replaced the Pure Food and Drug
Act in 1938 with the FDCA, Congress directed the FDA to
continue the food protection responsibilities of its
predecessor agency.115 The FDA has carried out that
110. Ilyse D. Barkan, Industry Invites Regulation, The Passage of the Pure
Food and Drug Act of 1906, 75 AM. J. PUB. HEALTH 18, 21 (1985) (footnotes
omitted); see also INST. MED & NAT’L RESEARCH COUNCIL, Ensuring Safe Food
from Production to Consumption 21–22, 26–27 (1998); Jillian London, Tragedy,
Transformation, and Triumph: Comparing the Factors and Forces that Led to the
Adoption of the 1860 Adulteration Act in England and the 1906 Pure Food and
Drug Act, 69 FOOD & DRUG L. J. 315 (2014).
111. Pure Food and Drug Act § 7, 34 Stat. at 769–70 (1906).
112. Id. § 8, 34 Stat. at 770. Interestingly, Congress also provided that a food
was misbranded if it did not “bear a statement on the label of the quantity or
proportion of” several components that would today be labeled controlled
substances, including “cannabis indicia.” Id.
113. Id. §§ 4–5, 34 Stat. at 769.
114. See The 1906 Food and Drugs Act and Its Enforcement, U.S. FOOD & DRUG
ADMIN., https://www.fda.gov/AboutFDA/WhatWeDo/History/FOrgsHistory/Evolv
ingPowers/ucm054819.htm (last updated Feb. 1, 2018).
115. See Food, Drug, and Cosmetic Act of 1938, 21 U.S.C. §§ 321, 331 (2018);
1938, Food, Drug, Cosmetic Act, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/
AboutFDA/WhatWeDo/History/FOrgsHistory/EvolvingPowers/ucm054826.htm
(last updated Feb. 1, 2018); Drugs and Foods Under the 1938 Act and Its
Amendments, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/AboutFDA/What
WeDo/History/FOrgsHistory/EvolvingPowers/ucm055118.htm (last updated Feb.
1, 2018). Since then, Congress has also enacted the Food Safety Modernization
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mandate by issuing regulations or guidance documents and
by taking enforcement action when necessary.116
That history is particularly important here because the
appropriations rider does not state or suggest that Congress
intended to restrict the FDA’s authority to protect the public
against an unsafe food product. The FDCA and the
Controlled Substances Act are two entirely separate laws;
the latter does not refer to the former, let alone expressly
repeal any portion of it. Accordingly, the appropriations rider
could limit the FDA’s authority only if it repealed by
implication the relevant provisions of the FDCA dealing with
food products. That, however, would be a difficult hurdle to
overcome. A settled rule of statutory interpretation is that
two acts of Congress should be construed in a manner that
harmonizes their operation, rather than conflict with each
other. The Supreme Court has noted that the “rarity” of
Act, Pub. L. No. 111-353, 124 Stat. 3885 (2011), to enhance the FDA’s ability to
protect the food supply.
116. For example, the FDA has recognized that lead can contaminate candies
eaten by children and has set limits as to the maximum amount permitted (1 part
per million). See, e.g., U.S. DEP’T OF HEALTH & HUMAN SERVS., FOOD & DRUG
ADMIN., GUIDANCE FOR INDUSTRY: LEAD IN CANDY LIKELY TO BE CONSUMED
FREQUENTLY BY SMALL CHILDREN (2006); U.S. DEP’T OF HEALTH & HUMAN SERVS.,
FOOD & DRUG ADMIN., SUPPORTING DOCUMENT FOR RECOMMENDED MAXIMUM
LEVEL FOR LEAD IN CANDY LIKELY TO BE CONSUMED FREQUENTLY BY SMALL
CHILDREN (2006); U.S. DEP’T OF HEALTH & HUMAN SERVS., FOOD & DRUG ADMIN.,
GUIDANCE FOR INDUSTRY: LETTER TO MANUFACTURERS, IMPORTERS, AND
DISTRIBUTORS OF IMPORTED CANDY AND CANDY WRAPPERS (1995); see also U.S.
DEP’T OF HEALTH & HUMAN SERVS., FOOD & DRUG ADMIN., FOOD DEFENSE
GUIDANCE DOCUMENTS & REGULATORY INFORMATION (2017) (collecting
memoranda and information); U.S. DEP’T OF HEALTH & HUMAN SERVS., FOOD &
DRUG ADMIN., MITIGATION STRATEGIES TO PROTECT FOOD AGAINST INTENTIONAL
ADULTERATION: WHAT YOU NEED TO KNOW ABOUT THE FDA REGULATION:
GUIDANCE FOR INDUSTRY SMALL ENTITY COMPLIANCE GUIDE (2017); U.S. DEP’T OF
HEALTH & HUMAN SERVS., FOOD & DRUG ADMIN., CNTR. FOR DRUG EVALUATION AND
RESEARCH, CNTR. FOR BIOLOGICS EVALUATION AND RESEARCH, GUIDANCE FOR
INDUSTRY, WARNINGS AND PRECAUTIONS, CONTRAINDICATIONS, AND BOXED
WARNING SECTIONS OF LABELING FOR HUMAN PRESCRIPTION PRODUCTS AND
BIOLOGICAL PRODUCTS—CONTENT AND FORMAT (2011). If the FDA were to find
that THC-infused food products are “adulterated” or “misbranded” under the
FDCA, the FDA could take action against edibles. Or if the FDA found that there
is a public health risk that accidentally ingested edibles would harm minors, the
FDA could act to protect minors from those products.
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instances in which it has found one federal statute to repeal
another by implication “is due to the relatively stringent
standard” for reaching that conclusion—namely, that there
is “an irreconcilable conflict” or “positive repugnancy”
between the two laws.117 That is not the case here. As a
result, “when two statutes are capable of coexistence,” as
these two are, “it is the duty of the courts, absent a clearly
expressed congressional intention to the contrary, to regard
each as effective.”118
Broadly construing the Rohrabacher rider would lead to
results that Congress clearly did not intend. There is scant
evidence that Congress wanted to disable the FDA from
preventing the public from being injured by a large batch of
edibles that became adulterated from a toxin or other
hazardous substance, whether due to the intentional
misconduct of an officer or employee of the firm that
manufactured the items, or due to the reckless or even
negligence conduct of employees on the “assembly line” so to
speak. Yet, a broad interpretation of the rider would deny the
FDA the ability to use its legal authority to prevent
undeniable harm to the consuming public. Congress did not
intend that anomalous result, and the rider does not demand
that the FDA stand aside and allow it to occur. For that
reason, it would make no sense to construe the rider to
prevent the FDA, even with the Justice Department’s
assistance, from halting the distribution and consumption of
food products to which someone had intentionally or
mistakenly added a hazardous substance simply because the
edibles also contained THC. If so, the result should be no
different if the FDA deems THC itself to be an adulterant,
given its potentially harmful effects on adults and minors.

117. J.E.M. Ag Supply, Inc. v. Pioneer Hi-Bred Int’l., Inc., 534 U.S. 124, 142–
43 (2001).
118. Id. at 143–44; see also POM Wonderful LLC v. Coca-Cola Co., 134 S. Ct.
2228, 2238 (2014).
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IV. THE OPTIONS OPEN TO THE FDA AND JUSTICE
DEPARTMENT
The FDA and Justice Department have the power to halt
or regulate the distribution of marijuana edibles. They also
have a range of options to pursue. What should they do? The
next subsections discuss those possibilities.
A. An Aggressive Approach
One option is for the FDA and Justice Department to
aggressively enforce federal law in every fashion that the
federal code allows. The agencies could undertake a full-bore
attack on the sale of medical and recreational marijuana,
including edibles, in states where they have been legalized.
Federal law enforcement officers could seize any and all
marijuana sold by brick-and-mortar dispensaries or online,
along with whatever cannabis is grown for commercial sale,
as well as arrest the parties who played a material role in a
distribution program. The Justice Department could bring
criminal charges against individuals for growing marijuana,
for manufacturing cannabis products, and for distributing
both. The department could prosecute the distribution
businesses in states like California and Colorado under the
federal controlled substances laws, as well as pursue the full
range of ancillary offenses that large-scale marijuana
distribution businesses might commit, such as racketeering
and money laundering.119 The FDA could complement the
work of the Justice Department by initiating the
administrative seizure of marijuana edibles on the ground
that they are adulterated and misbranded foods. Together,
the Justice Department and the FDA could close businesses
engaged in the commercial distribution of cannabis, deter

119. Money Laundering Control Act of 1986, Pub. L. No. 99-570, 100 Stat. 3207
(1986) (codified at 18 U.S.C. 1956–1957 (2012)); Racketeer Influenced and
Corrupt Organizations Act, enacted as § 901(a) of the Organized Crime Control
Act of 1970, Pub. L. No. 91-452, 84 Stat. 922 (codified at 18 U.S.C. §§ 1961–1968
(2012)).
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other entrepreneurs from opening new operations, and
effectively dissuade investors from seeking to underwrite
this business.
Those agencies might be willing to go forward with that
approach if three conditions were true: (1) they believed that
it is legally authorized, (2) they believed that it is a sensible
use of federal resources, and (3) they could count on the
support of the White House and Congress.120 It is unlikely
that the Justice Department and FDA will select that option,
however, for several reasons.
A full-frontal assault on the state liberalization schemes
would likely ignite a challenging political battle between the
states and members of Congress on one side and the
Executive Branch on the other. At present, more than forty
states and the District of Columbia allow marijuana itself or
one of its constituents to be used for medical purposes.121
States could enlist the support of a large majority of the
Senate along with the representatives from the relevant
states, one of which is California, which alone has fifty-three
members of the House. For public and media support, those
states and the members of Congress would showcase the
patients who use some form of marijuana to alleviate their
suffering as they cross the River Styx, as well as the
children—and their parents—who use marijuana to deal
with seizures.122 Indeed, the pictures of patients being
120. Cf. Cully Stimson, How Trump’s DOJ Can Start Enforcing Federal
Marijuana Law, DAILY SIGNAL (Feb. 27, 2017), http://dailysignal.com/2017/02/27/
how-trumps-doj-can-start-enforcing-federal-marijuana-law/.
121. NAT’L ACAD. REP., supra note 5, at 68 & Fig. 3-1, 74; Kosa et al., supra note
15, at 57.
122. See, e.g., Colorado Girl Sues Jeff Sessions to Legalize Medical Marijuana
Nationwide, FOX NEWS (Nov. 12, 2017), http://www.foxnews.com/us/2017/11/12/
colorado-girl-sues-jeff-sessions-to-legalize-medical-marijuana-nationwide.html.
(“A Colorado girl [Alexis Bortell] who suffers from seizures joined a lawsuit to sue
U.S. Attorney General Jeff Sessions in a bid to legalize medical marijuana
nationwide. Alexis Bortell, 12, told FOX31 Denver she was diagnosed with
epilepsy and traditional medicine wasn’t helping her seizures. Her doctors in
Texas recommended an invasive brain surgery, but a pediatrician suggested
medical marijuana. . . . Bortell found that taking a drop of Haleigh’s Hope, a
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replayed on television over and over would probably carry
more weight in the court of public opinion than what the
members of Congress can bring to bear.
Attorney General Sessions may be willing to trigger a
large-scale controversy, but it is not clear that President
Trump is. In fact, the president has been noticeably quiet
about marijuana legalization since being sworn into office.
Moreover, the Trump Administration does not yet have in
office a Director of the Office of National Drug Control
Policy—the person who is responsible for developing,
coordinating, and articulating the nation’s response to drug
problems. Trying to move forward on this issue without an
appointee in that office would be like trying to move the ball
downfield without a quarterback.
There is an odd feature of our current marijuana
regulatory scheme resulting from the federalist nature of our
system of government. States, like Colorado, have
established state bureaus to regulate the distribution of
medical and recreational marijuana, which includes
approving businesses that may sell cannabis products.123
Federal law enforcement officials might be willing to shut
down the private retail sale of marijuana, but they would be
quite reluctant to prosecute state officials for implementing
a program required by state law.124 Charging state
strain of cannabis oil, twice a day prevented the seizures from coming back. She’s
been seizure-free for nearly three years, but she can’t return to Texas because
marijuana is illegal there. Colorado is one of several states that legalized
marijuana for medicinal and recreational use.”).
123. In Colorado, the Marijuana Enforcement Division of the Colorado
Department of Revenue is responsible for regulating medical and retail
marijuana. See COLO. CODE REGS. § 212-1 (2017) (medical marijuana rules); id. §
212-2 (retail marijuana rules); COLO. DEP’T REVENUE, ENFORCEMENT DIV.,
MARIJUANA (2017), https://www.colorado.gov/pacific/enforcement/marijuana
enforcement. In Washington, the Liquor and Cannabis Board has that
responsibility. See WASH. REV. CODE § 66.08.012 (2017); WASH. ADMIN. CODE §
314-55 (2017).
124. State and local law enforcement personnel are exempt from federal
criminal liability if they are “lawfully engaged in the enforcement of any law or
municipal ordinance relating to controlled substances.” 21 U.S.C. § 885(d) (2012).
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regulators would raise novel questions of “causation” in the
criminal law that the courts might decide against the
department.125 In any event, doing so would quite naturally
chill the relationship between federal law enforcement
officers and their state or local counterparts. Neither the
Justice Department nor the Department of Homeland
Security, nor their constituent agencies—such as the Federal
Bureau of Investigation, the Drug Enforcement
Administration, and the U.S. Secret Service—want to see
that happen. Federal law enforcement officers—especially
the Secret Service—partner with state and local
departments in a host of different matters, such as offering
security for the president whenever he leaves the White
House. If, in response to federal prosecution of state officials,
states and localities were to decline to assist federal law
enforcement agencies, the latter would be severely hampered
in their effectiveness to enforce federal law. Accordingly, the
federal government might not want to prosecute state

That provision appears directed at the situation in which state or local officers
take possession of a controlled substance during a search or seizure undertaken
to enforce state criminal law. Efforts to ensure the distribution of marijuana
under a state medical or recreational program would not qualify under that
exemption. See United States v. Rosenthal, 266 F. Supp. 2d 1068, 1079 (N.D. Cal.
2003) (“‘[L]awfully engaged” in “enforcing a law related to controlled substances”
must mean engaged in enforcing, that is, compelling compliance with, a law
related to controlled substances which is consistent . . . or at least not
inconsistent . . . with the Controlled Substances Act. Section 885(d) cannot
reasonably be read to cover acting pursuant to a law which itself is in conflict
with the Act.”), aff’d 454 F.3d 943, 948 (9th Cir. 2006) (“We agree with the district
court that cultivating marijuana for medical use does not constitute ‘enforcement’
within the meaning of § 885.”).
125. See 18 U.S.C. § 2 (2012) (someone who causes someone else to commit a
crime is responsible for that crime). Aside from raising proximate cause issues
that would exceed the ones discussed in Palsgraf v. L.I.R.R. Co., 162 N.E. 99 (N.Y.
1928), the prosecution of state officials, not for the commercial distribution of
marijuana, but for regulating that activity, might be the push that the Supreme
Court needs to finally adopt a mistake of law defense. See, e.g., Paul J. Larkin,
Jr., The Folly of Requiring Complete Knowledge of the Criminal Law, 12 LIBERTY
U. L. REV. (forthcoming 2018); Edwin Meese III & Paul J. Larkin, Jr.,
Reconsidering the Mistake of Law Defense, 102 J. CRIM. L. & CRIMINOLOGY 725
(2012).
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officials for doing their jobs.126
Focusing on recreational marijuana use is also likely to
be more socially valuable because recreational use programs
present a greater risk of encouraging teenagers to try
marijuana. Limiting marijuana use to terminally ill patients
or people suffering from painful, disabling diseases does not
necessarily weaken the stigma associated with marijuana
use or undermine the message that marijuana is a harmful
drug; the message sent by a medical use program can readily
be seen as one of compassion.127 By contrast, a recreational

126. Of course, if the Justice Department were not to bring charges against
state parties, the private defendants in marijuana cases would doubtless claim
that the federal government had irrationally discriminated against them by not
granting them the same leniency that state officials received. The litigation over
those claims would take years to resolve. The result is that, if the Justice
Department seeks to end both state medical and recreational marijuana
programs, the Justice Department cannot make a decision that does not have a
serious downside to it.
127. The Substance Abuse and Mental Health Administration, an arm of the
U.S. Department of Health and Human Services, has found that teenage
marijuana use has increased in Colorado but not in Washington from 2011–2015.
See U.S. DEP’T OF HEALTH & HUMAN SERVS., SUBSTANCE ABUSE & MENTAL HEALTH
SERVS. ADMIN., HHS Publication No. SMA–17–Baro–16–States–CO (2017) (“In
Colorado, an annual average of about 46,000 adolescents aged 12–17 (11.1% of
all adolescents) in 2014–2015 used marijuana in the past month. The annual
average percentage in 2014–2015 was not significantly different from the annual
average percentage in 2011–2012.”); U.S. DEP’T OF HEALTH & HUMAN SERVS.,
SUBSTANCE ABUSE & MENTAL HEALTH SERVS. ADMIN., HHS Publication No. SMA–
17–Baro–16–States–WA (2017) (“In Washington, an annual average of about
49,000 adolescents aged 12–17 (9.2% of all adolescents) in 2014–2015 used
marijuana in the past month. The annual average percentage in 2014–2015 was
not significantly different from the annual average percentage in 2011–2012.”).
Other studies have differed as to whether recreational marijuana laws lead to
increased marijuana use, particularly by minors. Most have found no such effect.
See, e.g., CAULKINS ET AL., MARIJUANA LEGALIATION, supra note 5, at 213; Esther
K. Choo et al., The Impact of State Medical Marijuana Legislation on Adolescent
Marijuana Use, 55 J. ADOLESCENT HEALTH 160 (2014); Sam Harper et al., Do
Medical Marijuana Laws Increase Marijuana Use? Replication Study and
Extension, 22 ANNALS EPIDEMIOLOGY 207 (2012); Deborah S. Hasin et al., Medical
Marijuana Laws and Adolescent Marijuana Use in the USA from 1991 to 2014:
Results from Annual, Repeated Cross-Sectional Surveys, 2 LANCET PSYCHIATRY
601, 601 (2015); Julie Johnson et al., The Design of Medical Marijuana Laws and
Adolescent Use and Heavy Use of Marijuana: Analysis of 45 States from 1991 to
2011, 170 DRUG & ALCOHOL DEPENDENCE 1, 6–7 (2017) (all concluding that state
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use program sends the message to minors that marijuana is
the same as alcohol, something reserved for adults and not
harmful when used in moderation. Studies also differ on the
question of whether medical marijuana programs encourage
teen use of cannabis; some say “yes,” others “no.” Yet, studies
of medical marijuana programs “cannot be generalized to
laws on recreational use,” according to the American Medical
Association, because recreational-use laws “may have much
broader effects through such factors as pricing, advertising,
availability, and/or implicit messages to teens that
marijuana use is acceptable or nonrisky.”128
A 2017 study published in the Journal of the American
Medical Association Pediatrics, however, found empirical

medical marijuana laws did not cause an increase in youth marijuana use); D.
Mark Anderson et al., Medical Marijuana Laws and Teen Marijuana Use 19–20
(Nat’l Bureau Econ. Research, Working Paper No. 20332). A few have found an
effect. See, e.g., Lisa Stolzenberg et al., The Effect of Medical Cannabis Laws on
Juvenile Cannabis Use, 27 INT’L J. DRUG POL’Y 82, 82 (2016) (surmising that state
medical marijuana laws spur increased marijuana use by juveniles by reducing
the social stigma from its use); Melanie M. Wall et al., Adolescent Marijuana Use
from 2002 to 2008: Higher in States with Medical Marijuana Laws, Cause Still
Unclear, 21 ANN. EPIDEMIOLOGY 714, 715–16 (2011) (noting increase but not
attributing a cause); cf. Katherine M. Keyes et al., How Does State Marijuana
Policy Affect US Youth? Medical Marijuana Laws, Marijuana Use and Perceived
Harmfulness: 1991–2014, 111 ADDICTION 2187, 2192 (2016) (concluding that the
passage of state medical marijuana laws is associated with “increases in
perceived harmfulness amount youth and that marijuana use has decreased
among youth with that view”); Rosalie L. Pacula et al., Assessing the Effects of
Medical Marijuana Laws on Marijuana Use: The Devil Is in the Details, 34 J.
POL’Y ANALYSIS & MGT. 7, 29 (2015) (concluding that states with marijuana
dispensaries protected by state law may see an increase in marijuana use by
adults and minors); see generally CAULKINS ET AL., MARIJUANA LEGALIATION, supra
note 5, at 212 (“There are now enough contradictory published findings that
advocates on any side can weave whatever story they will to tell.”). But see JT
Borodovsky et al., U.S. Cannabis Legalization and Use of Vaping and Edible
Products Among Youth, 177 DRUG & ALCOHOL DEPENDENCE 299, 305 (2017) (the
effect of marijuana legalization on use by minors may vary according to the
statute at issue); Wayne Hall & Michael Lynskey, Why It Is Probably Too Soon
to Assess the Public Health Effects of Legislation of Recreational Cannabis Use in
the USA, 3 LANCET PSYCHIATRY 900, 900, 904 (2016) (concluding that the current
short-term studies of recreational cannabis use may not predict the long-term
results given several identified but unanswered questions).
128. Cerdá et al., supra note 4, at 143.
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support for the belief that recreational marijuana laws can
encourage minors to use marijuana.129 The study found that
Washington State had seen a rise in recreational marijuana
use by minors after adults were permitted to use marijuana
recreationally in 2012.130 Colorado did not see the same
increase in minors’ use of cannabis once its recreational
program went into effect, the study found,131 but it concluded
that recreational marijuana laws, however, may pose a
greater risk in that regard.132 The upshot is that

129. See id. at 148.
130. The study noted:
The post-RML increase in adolescent marijuana use in Washington
could have several explanations. First, our findings suggest that
legalization of recreational marijuana use in 2012 reduced stigma and
perception of risk associated with marijuana use. A shift in social norms
regarding marijuana use may have, in turn, increased marijuana use
among adolescents in Washington. Second, legalization may have
increased availability, increasing adolescent access to marijuana
indirectly through third-party purchases. Third, legalization could have
decreased the price of marijuana in the black market, particularly after
the first grower licenses in Washington were issued in March 2014 and
the first stores opened in July 2014. . . . Fourth, the increase in
marijuana use observed in Washington could be due to other changes
occurring at the same time as RML rather than to RML itself.
Id. at 146–47 (footnotes omitted).
131. See id. at 147–48.
132. The study noted:
This difference may be related to the different degree of
commercialization prior to [recreational] legalization in Washington and
Colorado. Colorado had a very developed medical marijuana dispensary
system prior to legalization, with substantial advertising, to which youth
were already exposed. Washington, on the other hand, did not provide
legal protection to medical marijuana stores. Therefore, the degree of
commercialization and advertising of these collectives was substantially
lower than in Colorado. In addition, rates of perceived harmfulness in
Colorado were already lower than rates in Washington and non-RML
[recreational marijuana law] states prior to legalization. Preexisting low
levels of perceived harmfulness and high levels of use may have
constrained further short-term increases following RML enactment. The
longer-term effect of RML implementation on adolescent marijuana use
in Colorado is still to be determined.
Id. at 147–48 (footnotes omitted).
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recreational-use laws may lead to greater marijuana use by
adults and minors both by not only diminishing—or
eliminating—the stigma associated with marijuana use, but
also reducing the price of cannabis by increasing its
supply.133
There are, however, less aggressive steps that the FDA
and Justice Department can take.
B. A Cautious Approach
If the federal government concludes that challenging
medical use of marijuana would generate overwhelming
political opposition, there are smaller steps that the Justice
Department could take. To start with, it could focus on the
state laws authorizing the recreational use of marijuana. To
narrow its focus even further, the government could also
address the risk that marijuana sold for recreational use
could wind up being used by minors, to their detriment. That
would particularly be true in the case of any edible that
closely resembles—or could be mistaken by a minor to be—
candy. The government, therefore, could seek to prevent the
distribution of all edibles or only the ones that could readily
be mistaken for ordinary candy or a similar item. Finally,
rather than bring a criminal prosecution against individuals
or businesses for the sale of edibles, at least as a first step,
the Justice Department could enlist the support of the FDA
and seize adulterated edibles.
If the department decides to proceed in this manner, the
scenario could play out in two steps. Step one would be for
the FDA to declare that the addition of THC to any edible
renders the product “adulterated” under the FDCA. Step two
would be to initiate the seizure of any edible products offered
for retail sale.134 Given the popularity of edibles, those steps
133. Id. at 146–47; see also Wayne Hall & Michael Lynskey, Evaluating the
Public Health Impacts of Legalizing Recreational Cannabis Use in the United
States, 111 ADDICTION 1764, 1766 (2016).
134. See 21 U.S.C. § 334(g), (h) (authorizing the temporary administrative
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would have the short-run effect of reducing the supply of
THC, halving the profits from the sale of medical and
recreational marijuana, increasing the price of the smoked
form of marijuana, and driving people, adults and minors,
toward the comparatively more dangerous practice of
smoking cannabis.135 Or, the FDA could take two smaller
steps: (1) forbidding the sale of edibles that a reasonable
person could confuse with a legitimate baked good, candy, or
anything similar; and (2) requiring the packaging and sale of
any other edible to satisfy a list of requirements deemed
necessary to reduce the risk that children will accidentally
ingest that product. Those requirements could include the
demands that the states already place on the sale of
marijuana—such as the limitation to designated retail
outlets of distribution rights, the use of child-proof
packaging, and the imposition of labeling dictates that
clearly display the contents on the package and warn against
the potential consequences of use.136
There is precedent for the FDA to intervene in the sale
of marijuana products. On October 31, 2017, as part of its
“ongoing efforts to protect consumers from health fraud,” the
FDA issued a warning letter to four large companies selling
for the treatment of various diseases self-labeled dietary
supplements products containing cannabidiol, a nondetention of adulterated foods without a hearing); Ewing v. Mytinger &
Casselberry, Inc., 339 U.S. 594 (1950) (rejecting a Due Process Clause challenge
to the FDA’s authority to seize adulterated or misbranded food before a judicial
hearing on the FDA’s claim is held).
135. See supra note 11.
136. A more aggressive position would be to require states that want to sell
edibles to do so only from state owned and operated facilities. Some states have
that requirement for the sale of distilled spirits, so the concept is not a new one.
See, e.g., VA. CODE ANN. § 4.1-100 (2017) (defining “Alcohol,” “Alcoholic
beverages,” “Beer,” “Spirits,” and “Wine”); id. § 4.1-101 (creating the Virginia
Alcoholic Beverage Control Authority); id. § 4.1-103 (empowering the Board of
Directors of the Virginia Alcoholic Beverage Control Authority to sell distilled
spirits). No state currently follows that option so they would need to enact new
laws to govern the sale of edibles. Whether the federal government should
exercise its prosecutorial discretion to force the states to choose that option and
whether states should independently adopt it are beyond the scope of this Article.
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psychoactive substance found in marijuana that the FDA has
not approved for use in any drug for any purpose.137 In each
case, the FDA found that the company marketed a new drug
without prior FDA approval, as required by the FDCA, and
misbranded the drugs by claiming that they can be used for
the treatment of disease. The FDA took this action, as FDA
Commissioner Scott Gottlieb explained in an accompanying
press release, to protect cancer patients against companies
“that deliberately prey on sick people with baseless claims
that their substance can shrink or cure cancer.”138

137. See FDA Warning Letter from Maridalia Torres-Irizarry, San Juan Dist.
Dir., FDA, to Laura Fuentes, Green Roads of Florida LLC (Oct. 31, 2017),
https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2017/ucm5831
88.htm; FDA Warning Letter from Darla Bracy, L.A. Dist. Dir., FDA, to Will
Claren, CEO, Natural Alchemist (Oct. 31, 2017), https://www.fda.gov/ICECI/
EnforcementActions/WarningLetters/2017/ucm583205.htm;
FDA
Warning
Letter from CDR Steven E. Porter, Jr., L.A. Dist. Dir., FDA, to Joel Stanley, CEO,
Stanley Brothers Social Enterprises, LLC (Oct. 31, 2017), https://www.fda.gov/
ICECI/EnforcementActions/WarningLetters/2017/ucm583192.htm [hereinafter
Stanley Bros. FDA Letter]; FDA Warning Letter from CDR Steven E. Porter, Jr.,
L.A. Dist. Dir., FDA, to Tisha T. Casida, That’s Natural! Marketing and
Consulting (Oct. 31, 2017), https://www.fda.gov/ICECI/EnforcementActions/
WarningLetters/2017/ucm583197.htm.
138. The FDA said in a 2017 press release:
‘Substances that contain components of marijuana will be treated like
any other products that make unproven claims to shrink cancer tumors.
We don’t let companies market products that deliberately prey on sick
people with baseless claims that their substance can shrink or cure
cancer and we’re not going to look the other way on enforcing these
principles when it comes to marijuana-containing products,’ said FDA
Commissioner Scott Gottlieb, M.D. ‘There are a growing number of
effective therapies for many cancers. When people are allowed to
illegally market agents that deliver no established benefit they may
steer patients away from products that have proven, anti-tumor effects
that could extend lives. . . . We have an obligation to provide caregivers
and patients with the confidence that drugs making cancer treatment
claims have been carefully evaluated for safety, efficacy, and quality,
and are monitored by the FDA once they’re on the market,’
Commissioner Gottlieb added. ‘We recognize that there’s interest in
developing therapies from marijuana and its components, but the safest
way for this to occur is through the drug approval process—not through
unsubstantiated claims made on a website. We support sound,
scientifically-based research using components derived from marijuana,
and we’ll continue to work with product developers who are interested
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A Colorado company, for example, used an Internet
website to sell products that it claimed can be used in the
treatment of cancer, Alzheimer’s, diabetes, Chronic
Traumatic Encephalopathy, and other diseases, as well as
for pain relief.139 The FDA concluded that the products are
“drugs” for purposes of the FDCA because they are used “in
the diagnosis, cure, mitigation, treatment, or prevention of
disease and/or are intended to affect the structure of any
function in the body.”140 The products also did not fit within
the exception for dietary supplements because that exception
is unavailable when there are authorized clinical
investigations underway for the product, and two such
investigations are in progress for drugs containing
cannabidiol.141 The products, according to the FDA, are also
not generally recognized as safe and effective and therefore
are “new drugs” for purposes of the FDCA, which cannot be
introduced into interstate commerce without prior FDA
approval.142
Moreover, the FDA also concluded that the products
were “misbranded” under the FDCA. The FDCA deems a
drug misbranded unless there are adequate directions for its

in bringing safe, effective, and quality products to market.’
Press Release, FDA, FDA Warns Companies Marketing Unproven Products,
Derived from Marijuana, that Claim to Cure or Treat Cancer (Nov. 1, 2017),
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm583295.
htm); see also, e.g., Anna Edney & Jenifer Kaplan, FDA Cracks Down on
Marijuana Cancer Treatment Claims, BLOOMBERG TECH. (Nov. 1, 2017),
https://www.bloomberg.com/news/articles/2017-11-01/fda-cracks-down-on-medic
al-marijuana-cancer-treatment-claims; Sheila Kaplan, F.D.A Warns Companies
Against Claims that Marijuana Cures Diseases, N.Y. TIMES (Nov. 1, 2017),
https://www.nytimes.com/2017/11/01/health/fda-marijuana-false-claims.html;
Mina Zhang, FDA Targets Country’s Largest Cannabidiol Producer in Warning
over Cancer Claims, FORBES (Nov. 1, 2017), https://www.forbes.com/
sites/monazhang/2017/11/01/the-fda-targets-countrys-largest-cbd-producer-inwarning-over-cancer-claims/#3fff46493fb7.
139. See Stanley Bros. FDA Letter, supra note 137.
140. Id.
141. Id.
142. Id. (citing 21 U.S.C. § 321(p)).
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intended use—that is, directions a layperson can understand
to use a drug safely and effectively.143 In the case of a
prescription drug, the FDA has concluded that it can be used
safely only at the direction and under the supervision of a
licensed physician.144 The diseases at issue are ones that
cannot be diagnosed or treated without the supervision of a
licensed physician, which an Internet purchase does not
require. Moreover, it is legally impossible for a layperson to
write adequate directions for someone to use the company’s
drugs safely and effectively to treat those diseases.145 The
FDA therefore directed the company to correct the violations
or face legal action, which could include seizure of the
relevant products and an injunction against further
distributions.146
Ordinarily, it might make sense for the federal
government to leave to the states the freedom to experiment
with various regulatory regimes. States can then experiment
with different solutions to the problems discussed in this
Article. Insofar as those problems are due to use of edibles by
“marijuana tourists,” publicity might be a more efficient way
to prevent misuse. The states have regulations for edibles,
although they vary widely.147 Those factors argue in favor of
deferring a uniform, federal solution for any problems until
more evidence is in. At the same time, what those regulations
cover and how seriously they are applied might be open
questions, or at least subject to dispute. Some states might
be acting responsibly.148 Some states, however, have created

143. Id. (citing 21 U.S.C. §§ 352(f)(1) and 21 C.F.R. § 201.5 (2017)).
Recommendations by a “barista” at the local cannabis store would not qualify.
144. Id. (citing 21 U.S.C. § 353(b)(1)(A)).
145. Id.
146. Id.
147. Barrus et al., supra note 11, at 9 (“[C]urrently, the rules governing the
manufacturing and labeling of edibles varies dramatically from state to state.”);
see also, e.g., id. at 9–10.
148. See CAULKINS ET AL., MARIJUANA LEGALIATION, supra note 5, at 204 (“So as
a gross generalization, medical-marijuana regimes created by state legislatures
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medical marijuana programs that are effectively recreational
marijuana programs under a different name.149
What ultimately militates in favor of the FDA’s
intervention is this: Congress chartered the FDA to protect
the nation’s food supply by intervening where necessary to
prevent the distribution of adulterated foods. If the FDA
concludes that the addition of THC to a food product renders
it adulterated, there is no reason why the FDA should defer
to whatever answer the states offer on that subject.
Accordingly, if the Justice Department agrees to defend the
FDA’s legal position in court, there is no sound reason for the
FDA to forego enforcing the FDCA against marijuana
edibles. Federalism principles do not require the FDA to
stand aside and watch as adulterated edibles are sold.
Moreover, three related statutes are instructive here.
The first one is the Cigarette Labeling and Advertising Act
east of the Mississippi generally appear to be good-faith efforts to provide
compassionate access to people with well-defined conditions, while regimes
originally created by voter propositions farther west are extremely permissive
and easy to manipulate.”).
149. See id. at 511 nn.275, 277 & 279; Larkin, supra note 4, at 511–12 (“There
is considerable proof that many state medical marijuana programs are simply a
sham for the decriminalization of that substance. Consider the following:
according to a 2013 study, in Arizona merely seven of 11,186 applications for
medical marijuana had been denied. Only 2,000 patients registered for Colorado’s
medical marijuana program before the Justice Department announced in 2009
that it would not enforce the federal marijuana laws against individual patients
and caregivers. Colorado residents apparently listened because by March 2011,
there were more than 127,000 Colorado registrants. In Colorado, fewer than
fifteen physicians wrote more than seventy percent of all medical marijuana
recommendations, with the reason being severe or chronic pain in ninety-four
percent of the reported conditions. Michigan had fifty-five physicians certify
approximately 45,000 patients. California does not require patients to register to
receive marijuana for medical use, so the number of patients is a matter of
speculation. Estimates, however, are that the number increased from 30,000 in
2002 to more than 300,000 in 2009 and 400,000 in 2010. The California statute
permits a patient or caregiver to possess six plants, but it allows counties to
amend state guidelines. Humboldt County, which lies in the heart of the
Northern California marijuana farming, allows resident to grow up to ninetynine plants on behalf of a patient. Not surprisingly, there is also considerable
evidence that significant quantities of marijuana grown or sold for medical uses
have been diverted for recreational use.”) (footnotes omitted).
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(CLAA).150 The act states that it is federal policy “to establish
a comprehensive Federal program to deal with cigarette
labeling and advertising with respect to any relationship
between smoking and health.”151 The goals are to ensure that
“the public may be adequately informed about any adverse
health effects of cigarette smoking by inclusion of warning
notices on each package of cigarettes and in each
advertisement of cigarettes” and to prevent “diverse,
nonuniform, and confusing cigarette labeling and
advertising regulations with respect to any relationship
between smoking and health” from impeding the national
economy.152 To reach those goals, the act empowers the
Secretary of Health and Human Services (HHS) to
promulgate advertising requirements for cigarette
packaging.153 The second law is the Nutrition Labeling and
Education Act of 1990 (NLEA).154 It empowers the HHS
Secretary to promulgate nutritional labeling requirements
for commercial food products.155 The third statute is the
Poison Prevention Packaging Act of 1970 (PPPA).156 It
requires use of child-resistant packaging for prescription
drugs, over-the-counter drugs, household chemicals, and
other hazardous materials potentially dangerous to children.
The statute empowers the Consumer Product Safety
Commission (CPSC) to establish “technically feasible,

150. Pub. L. No. 88-92, 79 Stat. 282 (1965) (codified as amended at 15 U.S.C.
§§ 1333–41 (2012)).
151. Federal Cigarette Labeling and Advertising Act, 15 U.S.C. § 1331 (2012).
152. Id. § 1331(1)–(2).
153. See id. § 1333. The CLAA also leaves in place the Federal Trade
Commission’s authority to take action against unfair or deceptive acts or
practices regarding cigarette advertising. Id. § 1336.
154. Pub. L. No. 101-535, 104 Stat. 2353 (codified as amended at 21 U.S.C. §§
321, 337, 343, 343-1, 345, 371 (2012)). The NLEA amended the FDCA. See § 1(b),
104 Stat. at 2353.
155. See § 2, 104 Stat. at 2353–57 (codified as amended at 21 U.S.C. § 343(q)
(2012)).
156. Pub. L. No. 91-601, 84 Stat. 1670 (codified as amended at 15 U.S.C. §§
1471–77 (2012)).
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practicable, and appropriate” packaging standards for “any
household substance” if it found that doing so was necessary
“to protect children from serious personal injury or serious
illness resulting from handling, using, or ingesting” that
substance.157 In particular, the CPSC can prohibit the use of
packages “which it determines are unnecessarily attractive
to children.”158 The PPPA defines a “household substance” to
include “any substance” that is “customarily produced or
distributed for sale for consumption or use, or customarily
stored, by individuals in or about the household and which
is . . . a food as defined in” the FDCA.159 That definition
would include marijuana edibles.
Rather than leave the matter to the states, Congress
enacted those laws to empower the federal government to
establish national packaging and labeling standards for
items such as food, cigarettes, and household cleaning
products to inform adult consumers what they were
voluntarily or accidentally ingesting and to prevent minors
from mistakenly consuming such products. In each case,
Congress also directed a federal agency to develop the
nationwide rules.160 The statutes therefore evince the
judgment that it is a national responsibility to protect the
public against the knowing or mistaken ingestion of
potentially harmful substances. Those policy choices are
157. Poison Prevention Packaging Act of 1970, 15 U.S.C. § 1472(a)(1)–(2)
(2012).
158. Id. § 1472(d).
159. Id. § 1471(2)(B).
160. A Memorandum of Understanding (MOU) between the FDA and the
CPSC recognized that the CPSC has the primary responsibility for regulating
food containers, but reserves the FDA’s right to regulate containers insofar as
there is a migration of particles from the container into the food or the container
is composed, in whole or in part, of a poisonous or deleterious substance that
might injure someone’s health. See U.S. FOOD & DRUG ADMIN., MOU 225-76-2003,
MEMORANDUM OF UNDERSTANDING BETWEEN THE U.S. CONSUMER PRODUCT SAFETY
COMMISSION AND THE U.S. FOOD AND DRUG ADMINISTRATION (1976). The MOU
recognizes that the FDA and CPSC share responsibility for making sure that food
containers do not injure a consumer’s health. The FDA and CPSC could negotiate
a similar agreement over the proper regulation of the packaging of edibles.
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entitled to respect.
CONCLUSION
Contemporary American society has decided that,
whatever may be the benefits and harms of liberalizing
marijuana use by adults, we should continue to outlaw the
sale of recreational-use marijuana to children and
adolescents. Even the states that permit recreational
marijuana use under state law draw the line between adults
and minors. Unfortunately, some companies pay only lip
service to that line. The ability to develop products that
closely resemble cookies, brownies, candies, and other
substances that are attractive to children and adolescents—
albeit, for different reasons—poses the risk that minors—
some accidentally, some intentionally—will consume
marijuana edibles found around the home or elsewhere. Any
use of marijuana by children and long-term use of marijuana
by adolescents poses health risks avoidable through federal
prohibition or regulation of edibles.
To avoid the danger to their health and safety, the
Justice Department and the FDA should take steps to
prevent adulterated and mislabeled edibles from harming
the public. Even if the Justice Department decides not to
challenge the state medical or recreational use programs, the
FDA should consider treating such edibles as adulterated
foods under the FDCA—taking whatever steps are available
to prevent the sale of any such products altogether—or to
allow sales to go forward only under strictly regulated
conditions. Doing so would help to reduce the danger that
edibles pose to the health and safety of children and
adolescents without materially interfering in state decisions
on how to regulate the distribution of medical-use marijuana
or the recreational use of that drug by adults.
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APPENDIX
FIGURE

1. A first Marijuana Edible example.161

FIGURE

2. A second Marijuana Edible example.162

161. Colorado Marijuana Bill: Banning Weed-Infused Gummy Bears,
WEEDLEX (July 4, 2016, 9:20 AM), http://weedlex.com/colorado-marijuana-billbanning-weed-infused-gummy-bears.
162. Robert J. MacCoun & Michelle M. Mello, Half-Baked—The Retail
Production of Marijuana Edibles, 372 N. ENG. J. MED. 989, 990 (2015).
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3. A third Marijuana Edible example.163

163. Veronika Bondarenko, This 59-year-old Mother of 2 is Making Millions
Selling Legal Marijuana Gummies, BUS. INSIDER (July 31, 2017, 3:00 PM),
http://www.businessinsider.com/wana-brands-nancy-whiteman-colorado-legalmarijuana-industry-edibles-entrepreneur-2017-7.

